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Conformation of the protein-free spliceosomal U2-U6 snRNA complex  
and remodeling with Mg2+ and proteins 
 
Splicing of precursor messenger RNA is an essential process in eukaryotes in which the 
non-coding regions (introns) are removed and coding regions (exons) ligated together to form a 
mature mRNA. This process is catalyzed by a multi-mega Dalton ribonucleoprotein complex 
called the spliceosome, which is assembled from five small nuclear ribonucleoproteins (snRNP) 
in the form of RNA-protein complexes (U1, U2, U4, U5 and U6) and hundreds of proteins. U2 
and U6 small nuclear (sn)RNAs are the only snRNAs directly implicated in catalyzing the 
splicing of pre-mRNA, but assembly and rearrangement steps prior to catalysis require numerous 
proteins. Previous studies have shown that the protein-free U2-U6 snRNA complex adopts two 
conformations in equilibrium, characterized by four and three helices surrounding a central 
junction. The four-helix conformer is strongly favored in the in vitro protein-free state, but the 
three-helix conformer predominates in spliceosomes. To analyze the role of the central junction 
in positioning elements forming the active site, we derived three-dimensional models of the two 
conformations from distances measured between fluorophores at selected locations in constructs 
representing the protein-free human U2-U6 snRNA complex by time-resolved fluorescence 
resonance energy transfer. Data describing four angles in the four-helix conformer suggest 
tetrahedral geometry; addition of Mg2+ results in shortening of the distances between 
neighboring helices, indicating compaction of the complex around the junction. In contrast, the 
three-helix conformer shows a closer approach between helices bearing critical elements, but 
addition of Mg2+ widens the distance between them and enhances the fraction of the three-helix 
 v 
conformer. Thus, in neither conformer are the critical helices positioned to favor the proposed 
triplex interaction suggesting the obligation for other components, spliceosomal proteins, to 
facilitate and stabilize the catalytically active conformation. We showed that incubation with the 
NineTeen Complex (NTC)-related protein RBM22, which has been implicated in the remodeling 
of the U2-U6 snRNA complex to render it catalytically active, favors the formation of the three-
helix conformer as seen in cryo-EM images of spliceosome. Binding analysis of interaction 
between yU2-U6 snRNA and a partial homologue of RBM22 in yeast, Cwc2, reveals a specific 
interaction between them, indicating a specific conformation of the active site stabilized by the 
protein.  These data suggest that although the central junction assumes a significant role in 
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Chapter 1: Introduction  
 
1.1 Ribonucleic acid (RNA): Structure, and functions 
 
1.1.1 Structure of components in RNA. 
The nucleic acids (DNA and RNA) are linear polymers of nucleotides, where a 
nucleotide is defined as a covalently attached unit of a heterocyclic nitrogenous base, a five-
carbon sugar (pentose) and phosphate residue. The common bases in nucleic acids are 
derivatives of pyrimidine (cytosine – C, uracil – U, and thymine - T) and purines (adenine – A 
and guanine – G). The pentose in RNA is ribose and in DNA, the pentose is deoxyribose; the 
difference between the two is the presence and absence of the hydroxyl (-OH) group on the 2¢ 
carbon in RNA and DNA, respectively (Figure 1.1). The sugar ring is not planar, but adopts 
puckered conformations, e.g. C-3' endo in RNA helices and C-2'-endo in DNA helices, shown in 
Fig 1.2. The pentose sugar is covalently attached to the base via a glycosidic bond to the C1¢ 
carbon to form a nucleoside. In RNA, the nucleosides named as cytidine, uridine, adenosine and 
guanosine while in DNA, the four nucleosides are deoxyadenosine, deoxyguanosine, 
deoxycytidine, and deoxythymidine (Table 1).  
Both DNA and RNA polymers are characterized by a sugar-phosphate backbone, formed 
by 5' phosphate of one nucleotide linked to 3'-OH group of the preceding one via a 
phosphodiester bridge (Figure 1.3). DNA is generally found in cells in an antiparallel double-
stranded form (which will be discussed later), whereas RNAs are transcribed from DNA as 









Figure 1.1: Structure of ribose in RNA (left) and 2'-deoxyribose in DNA (right). The difference 
is the presence of -OH group on 2' carbon in RNA and its absence in DNA. 
 
Figure 1.2: The common puckered conformations of furanose ring in DNA and RNA. Picture is 




Table 1: Structure of base, ribonucleoside, and ribonucleotides in RNAs. 






























Figure 1.3: Polymerization of nucleotides to form a single stranded RNA. The linkage forms 
between 5' phosphate of one nucleotide and 3'-OH group of the preceding one.  
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1.1.2 Secondary structure of DNA and RNA.  
 DNA and RNA duplexes are characterized by hydrogen bond formation (base pairing) 
between a complementary purine and pyrmidine to maintain a similar distance, and therefore 
consistent secondary structure, between glycosidic bonds. The most common base pairs in 
duplex structures, called Watson-Crick pairings, are A-T (A-U in RNA) and G-C (Figure 1.4).  A 
double stranded DNA helix contains two antiparallel strands that are held together by two 
hydrogen bonds for the A-T pair and three for the G-C pair. The most common conformation of 
DNA in solution is the B type helix, in which the deoxyribose adopts a C2' endo conformation, 
whereas in paired RNA it is the A-type helix, characterized by a C3' endo conformation 
necessary to avoid steric hindrance between the -OH group on the C'-2 carbon and the phosphate 
that would occur in the C2' endo conformation (Figure 1.5). RNA molecules, which do not have 
a complementary strand (as found in DNA), adopt Watson-Crick as well as non-Watson-Crick 
double- or single-stranded regions, and have a large degree of freedom in the backbone, resulting 
in significant conformational variability and plasticity. Therefore, a wide range of RNA motifs 
are formed when the juxtaposed complementary hydrogen bond donors and acceptors within the 
chain come together and form intra-strand base pairing. Examples of these motifs include stems, 
loops, budges, junctions are illustrated in Figure 1.6. In addition, secondary and tertiary 
conformational features are likely to undergo dynamic changes associated with biochemical 










Figure 1.4: The most common Watson-Crick base pairs found in DNA (A-T, G-C) and RNA (A-


















Figure 1.5: The common types of secondary structure in DNA and RNA (A-type helix in RNA, 








1.1.3 Functions of RNA polymers.  
DNA polymers are responsible for storing genetic information in the order of the 
nucleotides, whereas RNAs carry a broader range of biological functions. Historically, RNAs fell 
into several common types of passive intermediate in gene expression, with a central function of 
transferring information from DNA to protein in translation, including messenger (m)RNA, 
transfer (t)RNA, ribosomal (r)RNA. More specifically, mRNA carries the genetic code from a 
segment of DNA to ribosomes, the structure in which protein synthesis takes place; tRNA carries 
the amino acids into the ribosome; rRNA is the major component of the ribosome, recognizing 
and binding to mRNA and tRNA – but it was not until 2000 that it was definitely identified as 
the catalytically crucial component that catalyzes the synthesis of proteins.  
Many RNAs have been found to perform catalytic reactions even in the absence of 
proteins; these RNA enzymes are called ribozymes. Among the ribozymes found in prokaryotic 
and eukaryotic cells are nucleolytic ribozymes (most often found in prokaryotes and some 
organelles of lower eukaryotes), the small nuclear (sn)RNAs of the spliceosome, and the large 
subunit of the ribosome. Examples of nucleolytic ribozymes include the hammerhead and hairpin 
ribozymes, discovered in the satellite RNA of tobacco ringspot virus; these are folded strand of 
RNA that undergo autocatalytic self-cleavage during the viral replication process. Group I and 
Group II introns, first discovered and studied more than 30 years ago, are catalytic RNAs 
capable of self-splicing. The snRNAs of the spliceosome are similarly associated with a splicing 
process, and the many parallels with Group II introns suggest a common evolutionary ancestor. 
Due to the scope of this dissertation, I will now mainly focus on snRNAs in spliceosome. 
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1.2 Precursor messenger (pre-m)RNA splicing and the spliceosome. 
 
1.2.1 Precursor messenger (pre-m)RNA and the splicing reaction 
The removal of non-coding intervening regions (introns) and the ligation of flanking coding 
regions from precursor (pre)-mRNA, known as pre-mRNA splicing reaction, is an essential 
reaction in maturation of all eukaryotic mRNAs associated with protein synthesis as an early step 
gene expression. This two-transesterification reaction is catalyzed by the spliceosome, a complex 
and dynamic macromolecular machine. The spliceosome promotes the splicing reaction through 
two transesterification steps (Steitz and Steitz 1993; Moore and Sharp 1993): in the first step, the 
2′-OH of a specific adenosine residue of the intron performs nucleophilic attack at the 5′ of splice 
site (the end of the 5′ intron) (Parker et al. 1987), releasing the first exon and intron-exon 2 
intermediate (called lariat intermediate) (Peebles et al. 1986); in the second step, the newly free 
3′-OH of the first exon attacks the backbone phosphate linking the intron and second exon, 
releasing the lariat intron and a mature mRNA with the joined exons (Figure 1.7) (Peebles et al. 
1986; Steitz and Steitz 1993). These reactions were proposed to involve a two-metal ion center 
(Steitz and Steitz 1993), in which one Mg2+ ion activates the 2¢OH branch site nucleophile and 






Figure 1.7: Schematic representation of pre-mRNA splicing reaction adjusted from Alberts, Mol. 
Biol of the Cell, 4th Edition. The intron (yellow) is removed, and two exons (blue) are ligated 
together to form a mature mRNA.  
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1.2.2 Assembly of the spliceosome. 
The splicing of pre-mRNA is catalyzed by the spliceosome, a huge and dynamic 
ribonucleoprotein complex located in a eukaryotic cell’s nucleus involving five small nuclear 
ribonucleoprotein particles (snRNPs) and numerous non-snRNP splicing factors at different 
stages of assembly. Each snRNP consists of an (sn)RNA (U1, U2, U4, U5 and U6) associated 
with specific set of Sm proteins (reviewed by (Will and Luhrmann 2011).  
Spliceosome assembly (Figure 1.8) starts with an interaction between U1 snRNP and the 
5' splice site and recognition of the adenosine branchpoint (the residue presenting the 
nucleophilic 2′-OH) in the intron by the U1 snRNP and U2 snRNP, respectively, forming the 
pre-spliceosomal A complex. Then the U4/U6.U5 tri-snRNP joins to form the inactive pre-
catalytic B complex; upon entry, the U4 and U6 snRNAs are extensively paired, presumably to 
maintain the U6 snRNA, which will become the catalytic component, in a chemically inert form 
(Burke et al. 2015). The formation of a catalytically active site occurs through two stage 
transitions, from B to Bact followed by Bact to B*.  In the first part of this transition, U4 snRNA is 
unwound from U6 snRNA by the helicase Brr2 (Raghunathan and Guthrie 1998), and U6 
snRNA then pairs with U2 snRNA to form a complex defined by a central junction and multiple 
helical stems (Madhani and Guthrie 1992; Staley and Guthrie 1998); this complex comprises 
extensive intra- and intermolecular base-pairing sequences, and assists in positioning both the 5¢ 
splice site and the branch site sequence of the intron for the first cleavage reaction (Black et al. 
1985; Parker et al. 1987; Lesser and Guthrie 1993), as well as the metal ions directly implicated 
in splicing chemistry.  The resultant U2-U6 snRNA complex represents the only snRNAs 
directly implicated in catalysis (Fabrizio and Abelson 1990; Madhani and Guthrie 1992; 
McPheeters and Abelson 1992).  Also as part of this stage, the U1 and U4 snRNPs are released 
 13 
from the assembling spliceosome, and the U5 snRNP positions the 5¢ and 3¢ splice sites (Burge 
1999). This complex is called the Bact (activated) spliceosome. An extraordinary feature of the 
spliceosome is that its assembly has proceeded thus far without the definition of a distinct 
catalytic core; thus, despite the presence of all necessary components and exposure of the branch 
site, the critical catalytic elements of the U2-U6 snRNA-intron complex are fully established yet 
still inactive (Liu and Cheng 2012). Details from cryo-EM structure for Bact complex (Rauhut et 
al. 2016; Yan et al. 2016) has revealed that the branch site adenosine and active site are kept at a 
large distance (~50 Å), shielded by the U2 snRNP SF3a/b subcomplex, although positioned 
closed to the catalytic center. For splicing reaction to occur, this Bact complex, which was held 
together by Nineteen complex (NTC), undergoes multiple rearrangements to be further activated 
to become the B* complex. This transformation is mediated by Prp2, a DEAH-box RNA 
helicase.  The U2 snRNP Sf3a and Sf3b proteins, which have sequestered the branch site region 
in the Bact  are now destablized (Berglund et al. 2001; Kim and Lin 1996; Lardelli et al. 2010; 
Ohrt et al. 2012), thus ultimately liberates the branch site and 5' splice site allowing proximity of 
these two critical elements (Wlodaver and Staley 2014; Bao et al. 2017). The activated B* 
complex catalyzes the first step of splicing reaction. This step yields 5¢ exon and an intron-3′-
exon-2 intermediate (called lariat intermediate) and C complex which catalyzes the second step 
of trans-esterification results in ligation of two exon and forming the post-catalytic P complex. 
The spliceosome dissembles and snRNPs are recycled in the next splicing reaction. Thus, the 
ultimate goal of each of these protein-assisted stages is to usher new components to the 
assembly, catalyze RNA-RNA rearrangements, and to protect, expose, or juxtapose catalytic 
elements for catalysis at the appropriate time.  
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Detailed images of spliceosomes trapped in defined stages produced by cryo-EM studies, 
which will be discussed later, have contributed dramatically to our understanding of the 
landscape, interactions, and rearrangements of spliceosomal components throughout the cycle of 
assembly and activity in human (Bertram et al. 2017a; Bertram et al. 2017b) and yeast (S. pombe 
and S. cerevisiae; (Yan et al. 2015; Wan et al. 2016a; Yan et al. 2016; Yan et al. 2017; Bai et al. 






Figure 1.8: A schematic diagram of the cycle of spliceosome assembly and rearrangement (Will 
and Luhrmann 2011) illustrated the two-step mechanism of pre-mRNA splicing. The intron and 
exons are represented by solid line and boxes, respectively. The ordered interactions of small 
nuclear ribonucleoprotein particles (snRNPs) and spliceosomal proteins involved in each step to 




1.2.3 Recent cryo-Em studies of spliceosome at different stages  
Since 2016, there are numerous independent cryo-EM structural studies of spliceosome 
regarding detailed images at atomic resolutions of spliceosomes trapped in defined stages 
including complex B, Bact, C, C*, P, Intron Lariat Spliceosome (ILS) in yeast and B, Bact, C, C* 
in human (Wan et al. 2016a; Wan et al. 2016b; Bai et al. 2017; Bertram et al. 2017b; Wan et al. 
2017; Bai et al. 2018; Wan et al. 2019b) (Figure 1.9). In each of these cryo-EM studies, 
extensive information regarding the structure as well as the position of spliceosomal components 
has come to light; however, we will mainly focus on the elements of interest in Bact and B* 
complex. More specifically, rearrangements in RNA network and position of some intergral 
spliceosomal proteins from Bact to B* will be discussed in this dissertation. 
Cryo-EM images reveals that the structure of U6 snRNA in the active site which forms 
an internal stem loop (ISL) and helices (Helix Ia, Ib) with U2 snRNA from Bact to C complex, 
through 2 steps of splicing reaction in both yeast and human remains unchanged (reviewed by 
(Wan et al. 2019a; Fica 2020). In Bact in yeast, the catalytic metal M2 is coordinated by three 
phosphates from U6 snRNA and one from the 5’-guanine nucleotide of the 5' splice site. M1 is 
yet to be loaded into the catalytical active site, (reviewed by Yan et al. 2016; Shi 2017), 
however, two metal ions are already in position in human (Fica 2020). The Bact complex is kept 
inactive by positioning of the U2 snRNP SF3b subcomplex, separating the active site and the 
branch site by a large distance of 50 Å (Rauhut et al. 2016). The Prp19 and associated factors 
(called Nineteen complex or NTC) also join at this step and undergo extensive rearrangement to 
keep the 5' splice site near the active site. The B* complex is transient, formed at the final step of 
spliceosome activation and mediated by Prp2, in which, the RNA network is the same, the only 
difference is the position of some proteins that protect the two reactive moieties. Particularly, 
 17 
SF3a, SF3b, RES, and splicing factor Cwc24, Cwc27, once sequestered the branch site region, 
are now released. Therefore, they liberates the branch site and 5' splice site, which later be kept 
in close proximity by step 1-specific splicing factor Yju2. However, comparison with structure 
of C complex shows that Yju2 is insufficient for first reaction (Liu et a, 2007; Yan et al. 2016), 
but requires Cwc25, for which, the adenosine and 5' splice site can be pushed even closer and 




   
Figure 1.9: A structural view of spliceosome, obtained by cryo-EM studies showing major 
complexes involving in assembly of spliceosome. Picture is from (Fica 2020). 
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1.3 U2-U6 snRNA complex 
 
1.3.1 Similarities between the Group II intron and U2-U6 snRNA complex of spliceosome.  
The splicing reaction of pre-mRNA catalyzed by the spliceosome yields the similar 
intermediate and the final products to those of Group II introns (a class of RNA enzymes that 
catalyze their own removal by a similar splicing reaction) suggesting splicing mechanism is 
identical in both systems (reviewed by Jacquier 1990). In fact, both group II intron and 
spliceosome catalyze the splicing reaction through a two-metal ion mechanism (Dayie and 
Padgett, 2008).   
Structurally, Group II intron’s sequence and secondary structure show parallel features to 
those of the snRNAs of the spliceosome. Group II intron (Figure 1.10) is highly conserved and 
characterized by six radiating domains named from Domain 1 to Domain 6 (or D1 to D6) 
(reviewed by (Pyle 2016), among which D5 has a highly conserved sequence leading to a 
hypothesis that D5 is the heart of the active site (Robart et al. 2014). D5 and U6 snRNA ILS 
have similar sequence as well as secondary structure (Huppler et al, 2002; Sigel et al. 2004) 
(Figure 1.11), sharing two important regions for catalytic activity: the catalytically essential triad 
AGC (CGC in some Group II introns) and the bulge (Boulanger et al. 1995; Schmidt et al. 1996). 
Mutagenesis studies in yeast and human suggest an important catalytical role for these two 
regions because mutation in these two regions lead to the loss of splicing activity (Fabrizio and 
Abelson 1990). Moreover, the U2 snRNA base pairing with the branch site of the introns is 




Figure 1.10: Secondary structure of the Oceanobacillus iheyensis group II intron. The structure is 
characterized by six radiating domains (D1 with some subdomains, D1(i), D1(ii), D1A, D1B, 
D1C, D1D1, and D1D2 to D6) which are depicted by different colors. Picture is adjusted from 
(Marcia et al. 2013) 
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Figure 1.11: Comparison of the structural features of group II intron and U2-U6 snRNA. Picture 
is adjusted from (Valadkhan and Manley 2002). Similarities in structure of D5 (left) and U6 ISL 
(right) in which both contains an invariant AGC triad and a bulged nucleotide.  
 
Interestingly, multiple similarities between self-splicing Group II intron ribozyme and the 
spliceosome suggest shared ancestry, and crystal structures of the Group IIC intron of O. 
Iheyensis provided important information about common features about the tertiary interaction 
involving distant elements and metal ions to form the active site (Toor et al. 2008). More 
specifically, the highly conserved D5 catalytical triad and nucleotides in the junction between D2 
and D3 (called J2/3) together with the bulged nucleotide of D5 form a triple helix in Group II 
introns (Toor et al. 2010) (Figure 1.12). The presence of this triplex helps positioning the 
catalytical elements that required for catalysis at close proximity. Analogy between critical 
sequence elements and ion-binding features of group II introns and spliceosomes led to the 
hypothesis of an analogous motif in spliceosome involving the ion binding site at the bulged U of 
the ISL, AGC triad, and the 3¢ end of the ACAGAGA loop (Keating et al. 2010) to form 




evidenced by cross-linking (Anokhina et al. 2013) and genetic mutations in yeast spliceosomes 
in their cellular environment (Fica et al. 2014) and fully supported by cryo-EM based models 
(Anokhina et al. 2013; Yan et al. 2016) –that established the absence of proteins in the 




Figure 1.12: The formation of triplex in Group II introns and that in the spliceosome. A: The 
triple helix formed between the catalytic triad CGC, J2/3 (junction between D2 and D3) and the 
bulged nucleotide of D5 in Group IIC intron. B: The tertiary interaction in the catalytically active 
yeast spliceosome. Nucleotides involving in the triplex are shaded gray. C: Schematic diagram of 
two metal binding sites in U6 ISL and triad. Picture is from (Bao et al. 2018). Nucleotides 
involving in metal ion binding sites are in white with purple border.  
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1.3.2 U2-U6 snRNA complex secondary structures. 
 The catalytic center of the spliceosome is a complex defined by the U2 and U6 snRNA 
(Fabrizio and Abelson 1990), the most highly conserved among the five snRNA sequences. 
Inter- and intra-molecular base pairing between U2 and U6 snRNA lead to the formation of two 
intermolecular helices, Helix I and Helix II, and the U6 intramolecular stem loop (ISL) 
surrounding a central junction (Figure 1.13). The ACAGAGA sequence within Helix I of U6 
snRNA is involved in 5′ splice site selection and in promoting both steps of the splicing reaction 
(Luukkonen and Seraphin 1998; Mefford and Staley 2009); the U2 snRNA sequence opposing 
this ACAGAGA segment pairs with a region of the intron to position the branch site residue. 
Helix III, while not observed in cellular (Anokhina et al. 2013) or spliceosomal (Yan et al. 2016; 
Bertram et al. 2017a) systems, may help juxtapose the pre-mRNA 5′ splice site and branch site 
(Martin-Tumasz et al. 2010).  
Early genetic studies in cells (Madhani and Guthrie 1992; Sun and Manley 1995) led to 
models for two alternative conformations of the U2-U6 snRNA complex: a four-helix junction 
(Figure 1.13A) and a three-helix junction (Figure 1.13B). Two models are different in the 
junction, characterized by pairing of the conserved invariant AGC triad of U6 snRNA: with 3 
nucleotides of U6 snRNA to extend the base of ISL in the four-helix conformation; and with 
three nucleotides of U2 snRNA to form Helix Ib in the three-helix conformation. Each of these 
models was corroborated in vitro for the protein-free yeast (S. cerevisiae) U2-U6 snRNA 
complex by solution NMR (Sashital et al. 2004; Burke et al. 2012; Abid Ali et al. 2016). Results 
from single-molecule FRET experiments suggest that the interconversion between two 
conformations described by the FRET efficiency between probes placed at the terminus of Helix 
II and the hairpin loop of the U6 snRNA ISL: high FRET efficiency attributed to the four-helix 
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junction model; and low FRET efficiency for the three-helix junction (Guo et al. 2009). In an 
attempt to reconcile the inconsistent results, Greenbaum and coworkers (Zhao et al. 2013) used 
biochemical structure probing and solution 19F NMR to examine conformational features.  
Results of their 19F NMR studies in protein-free human complex identified a mixture of 
conformations: in particular, they showed a predominant four-helix junction (86%) and a minor 
three helix-junction (14%) (Zhao et al. 2013) and exchange between the two conformations 
occurs on the subseccond timescale (Zhao et al. 2014). 
 
 
Figure 1.13: The proposed secondary structure of U2-U6 snRNA of the spliceosome. (A): 
Secondary structure of human U2-U6 snRNA complex in position with pre-mRNA just before 
splicing (Sun and Manley 1995); (B): The alternative secondary structure proposed in yeast 
spliceosome (Madhani and Guthrie 1992). The catalytic elements are highlighted: ACAGAG box 
in blue, AGC triad in pink and bulged U in orange. The red arrow shows the beginning of 
splicing reaction when the branch site, adenosine, attacks the 5' splice site. Picture is from 
(Rhode et al. 2006).  
 25 
Although a three-helix conformer has been identified in intact spliceosomes (Yan et al. 
2016); (Bertram et al. 2017b) and cellular systems (Anokhina et al. 2013), which will be 
discussed later, in vitro studies of the U2-U6 snRNA complex in its protein-free state have 
supported formation of two different secondary conformations. These two models are 
characterized by three and a four helices around the central junction (Sashital et al. 2004; Guo et 
al. 2009; Burke et al. 2012; Zhao et al. 2013; Karunatilaka and Rueda 2014) that are in dynamic 
equilibrium with each other (Zhao et al. 2013). The observation of alternative conformations is 
interesting because the conserved catalytic AGC triad is in a different pairing context in each 
conformer: it is paired with U6 snRNA to extend the base of U6 ISL in the four-helix variant and 
paired with U2 snRNA to form Helix 1b in the three-helix conformation. This difference 
suggests the possibility that the three-helix junction observed in spliceosome facilitates 
formation of the active site (Sashital et al. 2004). However, genetic experiment found that the 
four-helix fold maintains a critical role at an unspecified stage in human cells (Wu and Manley 
1989).  
 
1.3.3 The fundamental role of metal ions in the folding of the U2-U6 snRNA complex. 
Mg2+ is the most common metal ion involved in RNA folding and catalysis. Metal ion 
coordination helps stabilize the leaving group during both steps of Group II intron self-splicing 
and pre-mRNA splicing (Sontheimer et al. 1999). In the protein-free U2-U6 snRNA complex, 
three binding sites within the complex with Mg2+ has been identified by (Fabrizio and Abelson 
1992; Yu et al. 1995; Sontheimer et al. 1997; Gordon et al. 2000; Yean et al. 2000; Yuan et al. 
2007) that include the AGC triad in the junction, two G residue of the ACAGAGA loop of the 
internal loop between Helix I and Helix III and backbone of U74 residue in U6 internal stem 
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loop (Figure 1.12) suggesting that the catalytic triplex forms the binding pocket for two metal 
ions (Bao et al. 2018).  
 
1.4 Interaction of spliceosomal proteins (Cwc2 in yeast and RBM22 in human) with the U2-
U6 snRNA complex.  
Unlike Group II introns, a class of introns that can self-splice without help from proteins, 
spliceosomal snRNAs do not fold into a catalytically active structure without the obligatory need 
of spliceosomal proteins. Proteins are not only important in the recognition and pairing of the 
splice sites, but also in facilitate the RNA-RNA, RNA-protein, protein-protein interaction in the 
spliceosome to position the integral elements of active site for catalysis.  
Interaction with multivalent metal ions is necessary and sufficient to facilitate folding of the 
Group II intron into a catalytic form in the absence of proteins. In spliceosomes, although Mg2+ 
has an impact on the conformation of protein-free U2-U6 snRNA complex by nonspecific 
screening of RNA backbones near the central junction, it is not sufficient to create an active 
conformation to support the splicing reaction in yeast and human U2-U6 snRNA complexes 
because the stems bearing the catalytically critical components forming the active site are far 
apart in the protein-free state (Sashital et al. 2004; Burke et al. 2012; Guo et al. 2009; Burke et 
al. 2012; Zhao et al. 2013; Karunatilaka and Rueda 2014). However, evidence supports the need 
for spliceosomal proteins to facilitate formation and/or stabilization of an active conformation by 
the native U2-U6 snRNA complex (Hogg et al. 2010).  
The NineTeen Complex (NTC), named after the splicing factor Prp19 that provides scaffold 
for NTC, consists of at least 8 core protein components (Tarn et al. 1994; Fabrizio et al. 2009; 
Hogg et al. 2010), with larger number of associated proteins. The individual functions of these 
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proteins are not well understood, but they are thought to be involved in final RNA remodeling 
steps prior to the formation of the fully catalytic core. Among them, Cwc2 - a NTC associated 
protein - is believed to link the NTC to snRNA, due to having known motifs for RNA binding, a 
zinc finger (ZF) and RNA recognition motif (RRM) (Ohi and Gould 2002). Evidence suggests 
that Cwc2 binds to U6 snRNA at ISL, the ACAGAGA box and Helix I to stabilize Helix I during 
splicing (McGrail et al. 2009; Rasche et al. 2012; Hogg et al. 2014) (Figure 1.14) and form the 
link between NTC and spliceosome allowing NTC to regulate RNA-RNA interaction during 
splicing reaction (Bao et al. 2018). Data also implicate RBM22, an analogue of Cwc2 in human, 
binds directly to the internal stem loop (ISL) of U6 snRNA assumingly to stabilize formation of 
the triple-helical active site in human (Rasche et al. 2012).  
 
Figure 1.14: Interaction of Cwc2 to U2-U6 snRNA in yeast at U6 ISL and upstream of 
ACAGAGA box. The sites in U6 that crosslinked to Cwc2 are indicated by red circles, open 
circles represent weak; and closed circles represent strong crosslinks. Picture adjusted from 
(Rasche et al. 2012).  
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1.5 Specific questions need to be addressed. 
With tremendous progress recently from cryo-EM studies, the structure of spliceosome at 
different steps in splicing reaction has been better understood. However, the structural changes 
between these steps have not been well connected. Specifically, while it is clear that several of 
RNA structural components are integral parts of the catalysis of the splicing reaction, it is poorly 
understood how these RNA elements are brought into a catalytically active tertiary conformation 
as well as how metal ions get arranged in the active site of spliceosome. To enhance our 
understanding of the role of the central junction and of divalent metal ions as well as 
spliceosomal proteins in facilitating formation of the active structure, we have focused on the 
three following aims: 1) investigate the orientation of the helical stems of the human U2-U6 
snRNA complex in the absence of spliceosomal proteins and build a three-dimensional structure 
of hU2-U6 snRNA conformers; 2) Study the conformational changes within the complex with 
Mg2+ to learn more about the role of metal ions; 3) Investigate interaction between spliceosomal 
proteins (RBM22 in human and Cwc2 in yeast) and U2-U6 snRNA complex. To achieve these 
goals, we used time-resolved Förster resonance energy transfer (trFRET) to measure distances 
between stems of the wild type and mutant complexes, and dependence on added Mg2+ and 








Chapter 2: Conformations of U2-U6 snRNA protein-free complex and changes with metal 
ions. 
(This chapter contains material that have been adjusted from our published paper: Chu H., Perea 
W., Greenbaum, N.L. (2020) RNA, Jul;26(7):836-850. doi: 10.1261/rna.073379.119). 
 
2.1 Introduction 
Genetic studies proposed two alternative secondary models for the U2-U6 snRNA complex 
in cellular systems, different in the base pairing around the junction: a three-helix junction 
(Madhani and Guthrie 1992) and four-helix junction (Sun and Manley 1995). Each of the two 
models were corroborated separately by NMR structural analysis of protein-free RNA in solution 
(Sashital et al. 2004; Burke et al. 2012), respectively, although the authors did not fully discuss 
the possibility that two conformations might be present concomitantly or might interconvert. 
Later, in vitro studies of protein-free U2-U6 snRNA complexes by the Rueda and Greenbaum 
groups showed that two conformers coexist in solution with a small energy barrier and that they 
can be interconverted from one to another in a process enhanced by divalent metal ions (Guo et 
al. 2009; Zhao et al. 2013). In contrast with these findings, only the three-helix conformer has 
been identified by cross-linking in human cells (Anokhina et al. 2013) and by cryo-EM studies of 
both yeast and human spliceosome (Wan et al. 2016a; Wan et al. 2016b; Bai et al. 2017; Bertram 
et al. 2017b; Wan et al. 2017; Bai et al. 2018; Wan et al. 2019b). It is therefore likely that in the 
context of intact spliceosomes, interaction with spliceosomal proteins and divalent metal ions 
favors formation of the three-helix conformer.  
The U2-U6 snRNA complex binds catalytically essential metal ions in the U6 ISL, the AGC 
triad in Helix I and two G nucleotides in ACAGAGA loop between Helix I and Helix III 
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(Fabrizio and Abelson 1992; Yu et al. 1995; Sontheimer et al. 1997; Gordon et al. 2000; Yean et 
al. 2000; Yuan et al. 2007); as evidenced by genetic experiments (Fica et al. 2014) and cryo-EM 
images (Bertram et al. 2017b; Zhang et al. 2017; Zhan et al. 2018), these structural elements fold 
to form a triple-helical active site analogous to that seen in crystallographic models of the Group 
II intron (Toor et al. 2008; Keating et al. 2010). Catalytic activity, although at very low yield, 
performed by protein-free U2-U6 snRNA complex emphasizes on the importance of snRNA 
components in the spliceosomal reaction (Valadkhan et al. 2009) and that it is capable of doing 
splicing reaction without proteins. We speculate that the helical stems bearing catalytically 
critical elements must undergo rearrangements, whether in the junction of U2-U6 snRNA 
complex or in stem orientation around the junction, allowing those regions to be in close 
proximity and form the triple interaction, and that the presence of Mg2+ enhances stabilization of 
the active conformer. To examine that hypothesis, we first investigated the orientation of helical 
stems of the human protein-free U2-U6 snRNA complex in the ground state and changes with 
Mg2+.  
To pursue this goal, we chose to use Fluorescence Resonance Energy Transfer (FRET) 
measurements as an approach to learn about the conformation of human U2-U6 snRNA complex 
in the ground state and changes upon adding Mg2+.  Ensemble and single-molecule (sm)FRET 
techniques have been used to analyze orientations of stems around Holliday junctions in DNA 
(Clegg et al. 1994), junctions in hairpin and other ribozymes (Walter et al. 1998; Liu et al. 2007; 
Tan et al. 2003), Group II introns (Steiner et al. 2008), and the junction in spliceosomal the U2-
U6 snRNA complex (Yuan et al. 2007; Guo et al. 2009; Karunatilaka and Rueda 2014); time-
resolved luminescence resonance energy transfer was used to estimate locations of multiple ion-
binding sites in a protein-free U2-U6 snRNA complex (Yuan et al. 2007). In this work, we used 
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time-resolved FRET measurements because of its advantages (discussed in section 2.2 below) to 
probe three-dimensional orientations concurrently of stems around three- and four-helix 
junctions of the protein-free U2-U6 snRNA complex, as well as Mg2+-dependent changes in the 
distribution and conformations of those junctions. Ultimately, the results will help us learn about 
the flexibility in the junction within which the activation of the active site might occur.  
 
2.2 Fluorescence Resonance Energy Transfer: Principles and Technique 
Förster (Fluorescence) Resonance Energy Transfer (FRET) is a nonradiative energy 
transfer process between an excited-state fluorescence donor (D) molecule and a ground-state 
acceptor (A) over a distance of 10-100 Å. Fluorophore D absorbs a photon when excited at an 
appropriate wavelength and non-radiatively transfers energy to the nearby A, which can be either 
another fluorophore or a quencher (Figure 2.1A upper). Therefore, the emission spectrum of D 
must overlap with the excitation spectrum of A, allowing the energy to be transferred and from 
which the rate of energy transfer can be determined. 
The efficiency of this energy transfer is inversely proportional to the sixth power of the 
distance between donor and acceptor; therefore, FRET is very sensitive to nanoscale changes 
(Figure 2.1B). Hence it is a powerful technique to provide insights into the conformational 
arrangement of nucleic acids, and changes in that conformation, within which probes D and A are 
covalently attached at two different sites.  
There are three main types of fluorophores: small organic molecules, fluorescent proteins, 
and quantum dots. Among them, small organic molecules are used widely because they are 
commercially available and more affordable. To choose the right donor-acceptor pair, one must 
consider several criteria. In order to maximize the FRET signals, the donor should have high 
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quantum yield (the ratio of the number of photons emitted to the number of photons absorbed) and 
the acceptor should have high extinction coefficient (represents how strongly a molecule absorbs 
light at a given wavelength), with a significant overlap in their spectra (Figure 2.1A lower). 
However, a problem arises when the acceptor gets excited at the donor excitation wavelength, as 
it complicates the analysis of FRET data. The experimentally measurable distance is between 0.5-
1.5R0 with R0 is the Förster distance between D and A at which efficiency of energy transfer is 
50%, therefore, with a long-anticipated distance, a pair with a high R0 should be used. 
 
 
Figure 2.1: (A) (upper) Schematic diagram showing the concept of fluorescence resonance 
energy transfer. The donor is excited at the excitation wavelength and transfers energy 
nonradiatively to a nearby acceptor. (lower) The overlap between donor emission spectrum and 
acceptor excitation spectrum. (B) Correlation between FRET efficiency and distance. R0 is the 
Förster distance between D and A at which efficiency of energy transfer is 50%; r is distance 
between donor and acceptor (Note: the term R, instead of r, is used to denote inter-dye distance 
in the equations below). Picture is from (Qiao et al. 2021). 
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2.2.1 FRET measurements.  
Fluorescence measurements can be categorized into two types of measurement: steady-
state and time-resolved (Figure 2.2). Steady-state measurements, which are more common, are 
obtained by illuminating the sample with a continuous beam of light; the intensity of the 
emission spectrum of D and A is recorded. The steady-state intensity only reveals an average 
intensity, i.e. the cumulative intensity of several decays weighted according to the fractional 
popularion; therefore, information regarding individual populations of conformations of the 
macromolecule(s) cannot be obtained.  For time-resolved measurements, the sample is exposed 
to short pulses of light and the decay or emission intensity is recorded. Analysis of the resulting 
decay curve, including deconvolution into multiple contributing lifetimes from two (or even 
three) populations, allows for determination of information from a heterogeneous ensemble of 
inter-dye distances. Thus, the time-resolved decay can reveal multiple decay times from several 
co-existing conformations.  
 
Figure 2.2: The intensity of the donor emission is recorded in steady state FRET measurements 
(left), whereas the time decay is recorded in time-resolved FRET measurements (right). The 
curve represents the recorded signal for donor only (orange), donor in the presence of an 
acceptor (green), and equipment response (blue). Picture is from Principles of Fluorescence 
spectroscopy, Joseph R. Lakowicz, 3rd edition, 2010.  
 34 
2.2.2 FRET efficiency and distance calculation.  
The efficiency of transfer, (EFRET) is determined either from steady-state or time-resolved 
measurements. In steady state measurements, EFRET is experimentally determined based on the 
decrease in the fluorescence emission of the donor calculated by  
EFRET = 1-IDA/ID (equation 1) 
in which ID and IDA are fluorescence intensity of the donor in the absence or presence of the 
acceptor, respectively.  
In time-resolved measurements, EFRET is determined from the relative decrease in lifetime 
of D in the presence of A:  
EFRET = 1 – τDA/τD (equation 2) 
where τDA and τD are the lifetime of the donor in the presence or absence of the acceptor.  
In both cases, the distance between D  and A, R, is: 
     (equation 3) 
where R0  is the Förster distance between D and A at which EFREET is 50%.  
 Analysis of the exponential decay data derived time-resolved FRET measurements is 
often more complicated than that from steady state measurements. This is because the resultant 
curve represents contributions from more than one conformation. Therefore, if a macromolecule 
adopts several conformations, there will be several lifetimes, and analysis requires fitting decay 
curves obtained from time-resolved measurements with multiple-exponential equation (equation 
4), each yielding αi (fractional amplitude associated with each lifetime) and τi (lifetime 
components of D), from which the average lifetime can be calculated (equation 5). 
𝐼(𝑡) ='𝛼𝑖𝑒𝑥𝑝	(−𝑡/τ𝑖)
!
 (equation 4 ) 
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       τavg = ∑ 𝛼𝑖τ𝑖"!#$   
 
(equation 5) 
where	∑ 𝛼𝑖 is normalized to unity.  
Distances obtained from the population of lifetimes in time-resolved measurements from 
which EFRET is calculated should be the same as that obtained from steady-state measurements. 
For time-resolved FRET measurements performed in this dissertation, curves are best fit by a 
single-exponential equation if there is only one uniform distance between the D and A, meaning 
one conformation; and a biexponential equation if two distinct distances corresponding to two 
conformations exist, in which case, the curves are deconvoluted into two individual lifetimes, t1 
and t2, each with its fractional contribution to the total: t1+s1 with relative amplitude of a1 and 
t2+s2 with relative amplitude of a2 in which si represents the standard deviation for lifetime i. 
The quality of fit was judged by reduced chi-squared value (reduced χ2), which is expected to be 
near unity for a good fit 
 
2.3 Experiment Designs 
 
2.3.2 RNA constructs 
To determine three-dimensional conformations of stems surrounding the central junction 
of the protein-free U2-U6 snRNA complex, we first designed, prepared, and paired RNA 
oligomers labeled to which fluorescent dyes were attached at designated sites. Modifications in 
the designed constructs to permit investigation of the roles of different structural elements of the 







Figure 2.3: Schematic diagram showing sequence mutations in RNA constructs used in these 
studies. (A): the native sequence of hU2-U6 snRNA complex; (B) the position of modified 
sequences in RNA constructs. In each diagram, the U6 snRNA fragment is in black and the U2 
snRNA fragment is in blue. Each of the modified constructs may contain one or more of the 
modifications: some nucleotides in U2 snRNA opposing U6 snRNA are modified (red) to close 
the ACAGAGA loop (dotted line in red); the pentaloop in U6 ISL (dotted line in green) is 
removed and a new tetraloop GCAA (green) is introduced to connect U2 and U6 snRNA; 
nucleotides in stem I (purple) are modified to favor the formation of four-helix junction. Detail 
on each of these modifications in each of the constructs is explained in the next page and in 
Figure 2.4.  
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To create a pairing representing the human U2-U6 snRNA complex with the native (WT) 
sequence in the region of the central junction that would be amenable to measurement of 
distances between helix termini by FRET, we designed two strands: 1) a 32 nucleotide truncated 
U6 strand started from the 5¢ terminal end of U6 snRNA (i.e. starting at G33, 8 nucleotide 
upstream of the ACAGAGA sequence), and terminated just before the hairpin pentaloop of the 
ISL, synthesized by IDT; and 2) a U6-U2 “chimeric” oligomer starting immediately 3¢ of the ISL 
hairpin loop and connecting with the 5¢ stem of U2 snRNA at the end of Helix II via a GCAA 
tetraloop to the U2 snRNA strand through U46 of the native sequence. The native sequence at the 
5¢ terminus of the human U6 snRNA oligomer includes nine nucleotides capable of forming 
Watson-Crick base pairs with complementary nucleotides at the 3¢ end of the U2 snRNA 
oligomer. Although we observe these base pairs in vitro (Zhao et al. 2013), this pairing has been 
shown not to occur in vivo (Anokhina et al. 2013) but since the duplex formation observed in the 
absence of other spliceosomal components is useful for measurement of FRET-based distances 
between termini of stems, and thus of angles, between Helix I and the U6 ISL, we have 
maintained such a duplex in each of our constructs.  
To create a construct that focused solely on the native junction without the added 
flexibility in the Helix I/III stem from the large open ACAGAGA region, we modified the 
sequence of U2 snRNA opposing the ACAGAGAA loop of U6 snRNA to form a 
complementary Helix I/III stem (WTDL; Figure 2.4A). All nucleotides within the region forming 
the central junction are present in the wild type sequences; modifications include truncation of 
sequence regions beyond paired stems and, in some cases, removal of the ISL pentaloop, a 
change in the 3¢ terminal nucleotide of the truncated U6 strand (U64) and the 5¢ nucleotide of the 
chimeric U6/U2 strand (A70) to create a C-G pair (maintaining base pairing adjacent to the 
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deleted hairpin loop of U6 ISL) and facilitate transcription of the chimeric strand. The chimeric 
strand was prepared by in vitro transcription techniques using double-stranded DNA templates 
(IDT) and T7 polymerase overexpressed and purified in the laboratory, followed by gel 
purification and electroelution of the final product.  
We next used a construct, based on WTDL, that we had previously designed (Zhao et al. 
2013) to limit junction conformation to the four-helix conformer by mutating several U2 Stem I 
nucleotides: mutating G12-C21 to C12-G21, as well as U17U18 to C17G18 (Construct 4HJDL1). 
These modifications disrupt base pairing of the AGA triad in U6 snRNA to U2 snRNA 
(disfavoring the three-helix fold) and stabilize Stem I (to favor the four-helix fold), respectively. 
All other modifications described in WTDL, including the closing of the ACAGAGA loop, were 
maintained (Figure 2.4B).  
To measure the distance between the U6 ISL and Helix II while maintaining the same 
junction features as in 4HJDL1, we made changes to the design of 4HJDL1 to enable attachment 
of linkers and dyes to the 5¢ terminus of U2 snRNA (4HJDL2; Figure 2.4C).  In design of this 
construct, the connecting tetraloop GCAA was “moved” from the end of Helix II to the end of 
Helix I/III, resulting in a chimeric strand starting with the 5¢ terminus of U2 snRNA, and 
connecting to the 5¢ end of U6 snRNA by the tetraloop. We also removed five base pairs from 
Helix III (this helix was not dye-labeled in this experiment) to compensate for addition of the 
loop and added two base pairs to U6 ISL to increase dye-labeling yield. The 5¢ 31-nucleotide 
fragment representing the 5¢ side of the ISL and U6 strand of Helix II were synthesized by 
Dharmacon (with a 5¢ phosphate to facilitate linker attachment); the longer chimeric strand 
representing U2 snRNA and the 5¢ segment of U6 snRNA was generated by in vitro transcription 
as described above.  
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To measure the distance between 5¢ of U2 snRNA and 5¢ of U6 snRNA, we designed a 
construct favoring four-helix junction fold used in Construct 4HJDL3 (Figure 2.4D). The 
mismatch (U6)U90-(U2)U10 in Helix II was modified to form a Watson-Crick pair by changing 
(U2)U10 to (U2)A10; Helix II and Helix III have the same number of base pairs as 4HJDL1.  
To measure the distance between 5¢ of U6 snRNA and internal U16 of Stem I, we 
designed construct 4HJDL4 (Figure 2.4E).  The U6 strand, which represents the U6 snRNA 
sequences between Helix III and Helix II, including the ISL pentaloop, was transcribed and 
purified as above. The U2 strand containing a linker-labeled internal U16 was synthesized 
chemically (IDT); U16 was incorporated as the amino-modified phosphoramidite called 
iUniAmM. The six-carbon linker is attached covalently through the C5 of uridine, providing a 
free primary amine that attaches to a fluorophore by the same reaction as attachment at the 
terminus of an oligomer.  
Finally, to assess the impact of the ACAGAGA loop on angles between Helix I/III and 
the ISL as a result of flexibility or long-range interactions with elements in the ISL, we 
reintroduced the native U2 snRNA sequence opposing the U6 ACAGAGA sequence in two 
constructs, WTDL and 4HJDL1 to create WT and 4HJ, respectively (Figure 2.4F and 2.4G). 
All transcribed RNAs were purified by ethanol precipitation and electrophoresis on a 
20% polyacrylamide gel, followed by excision of the desired band. Desired RNA bands were 
eluted with an Elutrap device at 4	℃, 100 V overnight. The concentration of RNA was 






















































Figure 2.4: Constructs representing the human U2-U6 snRNA complex used in these 
experiments. A): Wild-type junction in which the ACAGAGA loop is “closed” by pairing with a 
complementary sequence (shown in red), with Fluorescein as the Donor (D; Fl) and Cy3 as the 
Acceptor (A) on termini of helix III and U6 ISL, respectively (WTDL); (B): mutations in Stem I 
favor the four-helix conformer (individual nucleotide changed in red), also with a “closed” 
ACAGAGA loop and dyes on helix III and U6 ISL (4HJDL1); (C): four-helix mutant with 
“closed” ACAGAGA loop, and Fl and Cy3 dyes on termini of U6 ISL and Helix II, respectively 
(4HJDL2); (D): four-helix mutant with “closed” ACAGAGA loop with AF488 (D) and AF555 
(A) dyes on termini of Helix III and Helix II, respectively (4HJDL3); (E): four-helix mutant with 
“closed” ACAGAGA loop with AF488 and AF555 dyes on Helix III and Stem Loop I, 
respectively (4HJDL4); (F): wild-type U2-U6 junction with wild type ACAGAGA loop, and Fl 
and Cy3 on termini of Helix III and U6 ISL, respectively; (G): four-helix mutant with 
ACAGAGA loop, with Fl and Cy3 dyes on termini of Helix III and U6 ISL, respectively (4HJ) ); 
(H): The proposed three-helix junction conformer without a ACAGAGA loop. 
 
2.3.2 Pairing of strands 
The base pairing of all RNA constructs was performed in non-denaturing 15% PAGE gel. 
For each RNA complex, 40 pmol of each RNA strand (0.5 µl 80 µM RNA samples) were mixed 
and annealed by heating at 85℃ for 3 minutes and cooling at room temperature for 10 minutes 
prior loading on the gel in a buffer of Tris (30 mM)-HEPES (60 mM), pH 7.6, 30 mM NaCl, 1 
mM EDTA. As controls, individual strands were subjected to the same process. Samples were 
then applied to nondenaturing 15% PAGE at 4	℃, 120 V, for 4 hours in a buffer of Tris-HEPES, 
pH 7.6. Gels were stained with ethidium bromide and visualized under UV light at 302 nm 
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(and/or visualized by fluorescence of attached dyes). Complete pairing of two individual strands 
was confirmed by appearance of a single band with slower electrophoretic mobility than either of 
the individual strands. The shifted band shown in lane 3 and lane 6 with no residual bands 











Figure 2.5: Non-denaturing polyacrylamide gel electrophoresis used to analyze pairing of 
equimolar concentrations of RNA strands of U2-U6 snRNA constructs. Left: Pairing of strands 
of construct WT (see legend of Figure 2.4F). Lane 1: 32 nucleotide (nt) fragment representing 
the 5¢ region of U6 snRNA; Lane 2:  74 nt U6-U2 “chimeric” fragment; Lane 3: RNA strands in 
Lane 1 and Lane 2 paired to form construct WT. Right: Pairing of strands of construct 4HJDL3 
(Figure 2.4D). Lane 4: 44 nt U2 snRNA strand; Lane 5: 65 nt U6 snRNA strand; Lane 6: RNA 
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2.3.3 Labeing of RNA fragments with linkers and dyes 
As D-A pair for the experiments in this study, we chose fluorescein-Cy3 with R0 = 56 Å 
(Norman et al. 2000) due to high quantum yield of fluorescein (~95%) and outstanding high 
extinction coefficient of Cy3; and AF488-AF555 pair for their long R0, 70 Å, which benefits 
measuring long-anticipated distances between some sites within the RNA constructs. 
The donors (fluorescein NHS ester, AF488 NHS ester) and the acceptors (Cy3 NHS ester, 
AF555 NHS ester) were attached covalently to linker-modified 5¢ phosphate termini or a linker-
modified internal uridine residue (e.g. construct 4HJDL4) via a two-carbon (in the transcribed 
RNAs) or six-carbon (in the chemically synthesized RNAs) primary diamine linker (Figure 2.6).  
The two-carbon primary diamine linker was added to 5¢ phosphate termini using protocol Tech 
tip #30 provided by Thermo Scientific (ThermoFisher.com). A 10 times excess of fluorophore 
(250 μg dissolved in 14 μl DMSO) was added to 10 nmol of amine-modified RNA in 0.1 M 
sodium tetraborate buffer, pH 8.5, to a total volume of 100 μl in a dark room. The reaction 







Figure 2.6: A scheme showing the linker and dye labeling reaction.  R and F stand for RNA and 
fluorophore, respectively. A two-carbon diamine linker is attached to RNA via the 5' phosphate 
through which an amide bond forms between RNA and fluorophore. 
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The dye labeled RNAs were purified by ethanol precipitation followed by 20% 
polyacrylamide gel electrophoresis and eluted by a “crush and soak” method described by 
Sambrook, J., Fritsch, E. R., & Maniatis, T. (1989). The dye-labeling yield was determined by 
absorbance of RNA and the fluorophore at 260 nm and the excitation wavelength of each dye, 
respectively. The base pairing of labeled RNA strands was tested as described above to confirm 
that labeling did not diminish pairing efficiency.  
 
2.4. Results 
To analyze the role of the central junction in positioning the two helices critical to forming 
the active sites in both conformers, and to build a three-dimensional structural model of the 
orientation of the four helical stems of the majority form of the protein-free human U2-U6 
snRNA complex, we used time-resolved FRET technique to measure distances between termini 
of complexes formed by paired fragments representing U2 and U6 snRNA complex.  RNA 
constructs are described and shown in Figure 2.4. 
 
2.4.1 Steady state FRET measurement of the human U2-U6 snRNA complex.  
We first acquired inter-dye distance measurements between termini of Helix III and the 
U6 ISL of a U2-U6 snRNA construct, the two stems containing elements that interact to define 
the catalytic center by steady state measurements. In this construct (WTDL; Figure 2.4A), we 
replaced the sequence of U2 snRNA opposing the ACAGAGA loop with a complementary 
duplex to create a continuous stem. Although nucleotides in the 5¢ end of the U6 and the 3¢ end 
of the U2 snRNA sequences are capable of forming nine Watson-Crick base pairs to form Helix 
III, this duplex is not observed in cellular (Anokhina et al. 2013) or spliceosomal (Yan et al. 
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2016; Bertram et al. 2017a) systems. However, this helix forms in the protein-free RNA complex 
and is useful in these experiments for stabilizing the position of the attached dye on the 5¢ 
terminus of the U6 snRNA fragment.  In this case we measured FRET between a fluorescein 
Donor (D)-labeled 5¢ end of the abbreviated U6 snRNA strand and the Cy3 Acceptor (A)-labeled 
U6 ISL.  
Steady state measurement of FRET efficiency between D and A, calculated from the 
decrease in emission of D in the presence of A (corrected for emission of A alone when 
illuminated at the excitation wavelength of D, 495 nm; equation 1), was 13.7% (Figure 2.7). 
Using R0 = 56 Å for the fluorescein-Cy3 dye pair, this transfer efficiency corresponds to a mean 
distance of ~76 Å between the dyes. We note that previous enzymatic structure probing and 19F 
NMR experiments from our laboratory identified conformational heterogeneity of the wild-type 
junction of the protein-free human U2-U6 snRNA complex characterized by a mixture of three- 
and four helix conformers (Zhao et al. 2013) and identified the predominant fold in the protein-
free human U2-U6 snRNA complex under similar conditions as used here as the four-helix 
conformer. However, spectra derived from steady state ensemble FRET measurements do not 
provide information to distinguish individual distances in a heterogeneous system since it 













Figure 2.7: Steady state emission spectrum of fluorescein (Donor) attached to the 5' terminus of  
U6 snRNA as the only dye (black line), and with Cy3 labeled at 5' of U6-U2 chimeric RNA (blue 
line) in construct WTDL (Figure 2.4A) following excitation at 495 nm. Samples were in 150 nM 
RNA in Tris (30 mM)-HEPES (60 mM), pH 7.6, 30 mM NaCl, 1 mM EDTA (no added Mg2+).  
 
2.4.2 Time-resolved FRET of a U2-U6 snRNA complex with the wild-type junction 
To estimate distances in each of the major conformers in this heterogeneous system, as 
well as the distribution of the populations, we utilized time-resolved FRET. The advantage of 
this approach is that the decay curve of a pulse-excited donor dye transferring energy to a 
suitable acceptor dye contains rate/distance information for all D-A distances represented in an 
ensemble weighted according to fractional representation in the ensemble; deconvolution of 
decay curves thus allows determination of the relative populations of signals from multiple 







Using the same WTDL construct (Figure 2.4A), we first measured the decay of emission 
of D alone (with an unlabeled U6-U2 chimeric strand), followed by D in the presence of A, and 
fitted decay curves with single exponential or the weighted sum of two exponential curves. The 
time-resolved decay curve of the D alone was fitted by a single exponential curve with a 
lifetime,tD, of 4.05±0.008 ns and a CHI-square (goodness of fit; c2) value = 1.07. The decay 
curve for D in the presence of A was first fit with a single exponential curve with tDA of 
3.69±0.010 ns and c2 = 2.67, i.e. meaning not a good fit. Fitting the curve with two decay 
components, however, with lifetimes of 3.87±0.01 ns (fractional amplitude of 91.4%) and 
0.89±0.06 ns (fractional amplitude of 8.6%), for distances between the dyes of 93.0 Å and 45.3 
Å, respectively, yielded a far better overall fit (c2 = 1.15) (Figure 2.8). These two lifetimes 
correspond to an average distance of 80.0±2.2Å using equation 2, 3 and 5, similar to the result 
from steady state ensemble FRET (section 2.4.1). Our earlier finding that the four-helix 
conformer was by far the larger fraction (Zhao et al. 2013) suggests that it is likely to correspond 
to the larger distance, and that the minor three-helix conformer is associated with the shorter 
distance. The next task was to match each set of distances with the conformer it represents 




Figure 2.8:  The exponential decay fitting process for (A): fluorescein (Donor) undergoing FRET 
to Cy3 (Acceptor) in Construct WTDL. The blue decay curve is instrument response. The red 
decay curve is for fluorescein in response to pulses at 495 nm. The solid green curve was a best 
fit by a biexponential curve corresponding to two lifetimes of 3.87±0.01 (91.4%) and 0.89±0.06 
ns (8.6%). (B) Display of residuals derived from fit with a mono-exponential curve indicates a 
poor fit (CHISQ=2.67); (C) Display of residuals derived from fit with a biexponential curve 






2.4.3 Time-resolved FRET of the four-helix conformer: assignment of the conformer(s) 
present in the wild-type junction. 
To obtain distances related to individual conformers, we performed measurements using 
construct with a modification of nucleotides near the junction that favored the four-helix 
structure (construct 4HDL1; Figure 2.4B) and compared results with those for the wild-type 
junction (WTDL). Measurements of time-resolved FRET between the dyes in the construct 
4HDL1 labeled at the same sites as of construct WTDL indicated a fitted single exponential curve 
with a distance of 90.8±0.6 Å (c2 = 1.24), a value very similar to that of the deconvoluted four-
helix conformer and very different from that of the minor conformer, confirming that the longer 
lifetime component in the decay curve deconvolution corresponds to the four-helix conformer, 
and the smaller component with the shorter lifetime therefore corresponds to a three-helix 
conformer. Based upon the population of the two conformers identified from deconvolution of 
decay curves (discussed in section 2.4.2), we calculated a ΔG of 5.9 kJ/mol at 25 ℃ for the 
formation of the higher energy three-helix junction from the lower energy four-helix junction. 
This value is similar to the difference in energy of 4.7 kJ/mol calculated for the two conformers 
from the relative area under 19F NMR resonance peaks (Zhao et al. 2013). 
 
2.4.4 Measurement of other distances in the four-helix conformer. 
To contribute to the three-dimensional topology models of the two conformers of the 
protein-free human U2-U6 snRNA complex, we also determined angles between dye pairs at 
other sites within the complex.  In each case, we repeated time-resolved FRET measurements to 
determine inter-dye distances using constructs with dyes on different termini, and with either the 
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wild type or the helix mutated to form only the four-helix conformer. As in WTDL and 4HDL, 
the ACAGAGA loop was eliminated by extensive WC pairing.  
To measure the distance between the cleaved hairpin loop of U6 ISL and the terminus of 
Helix II we created a four-helix construct, 4HDL2 (Figure 2.4C), and labeled 5¢ termini with 
fluorescein and Cy3, respectively. Results of time-resolved FRET measurements indicated a 
distance of 73.0±1.0Å, triangulated into an angle of 110.1±2.4°. This angle calculation included 
an estimation that five U6 snRNA unpaired nucleotides (AAAUU) at the junction form a loop 
contributing ~5Å to the length of Helix II.   
For measurements between Helices II and I/III, we labeled the 5¢ termini of strands 
representing U2 snRNA (in Helix II) and U6 snRNA (in Helix III) (4HJDL3; Figure 2.4E). We 
used the AlexaFluor dye pair (AF488 and AF555) to take advantage of the longer R0 for the 
larger anticipated distance between the termini (Yuan et al. 2007). AF488 and AF555 have been 
shown by simulation to be relatively mobile in aqueous solution (Corry and Jayatilaka 2008); we 
therefore assumed they would behave like fluorescein in calculation of the length of RNA 
duplex. The distance between probes at 5ʹ termini of U2 and U6 snRNA was 97.0± 1.0 Å, which 
triangulated to an angle of 116.7±2.0º. 
Finally, to measure the distance between Stem I of U2 snRNA and Helix III (4HJDL4; 
Figure 2.4E), we measured time-resolved FRET between AF488 labeled at 5¢ of U6 snRNA and 
AF555 at internally labeled U16 of U2 Stem I. The distance from 5ʹ U6 snRNA to U2 stem I is 
85.2±0.8 Å, for an angle of 139.0±4.0°. These data have allowed us, for the first time, to create a 
three-dimensional model of the human protein-free U2-U6 snRNA complex in its four-helix 
form and calculated three-helix form (see section 2.3.7 below). 
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2.4.5 Translation of distance information into junction angles.    
Distances between two termini were translated into estimated angles between stems X 
and Y. Calculation of stem length assumed A-type helical stacking parameters and included the 
approximation that the Cy3 dye + linker stacked onto RNA helices, contributing ~2.6 Å, 
equivalent to an additional base pair, to the length of a helix. Fluorescein is mobile in solution 
due to its positive charge (Norman et al. 2000). To calculate the length of helices, we estimated 
the overall contribution of fluorescein to the length of RNA helices by performing time-resolved 
FRET on dye-labeled B-type DNA duplexes of 8 and 18 base pairs. Resulting data indicated that 
fluorescein with a two-carbon primary diamine linker contributes ~8.5 Å to the length of a 
duplex. 
From the distance between termini of helical stems and estimated lengths of the stems 
(Helices III-I and ISL), we estimated angles between stems. For construct 4HDL1, the stem 
formed by Helices I and III is a continuous A-type helix of 24 nucleotides (2.6 Å between 
centers of base pairs); with 8.5 Å extension for fluorescein and a 2 carbon amino linker and 5 Å 
due to addition of four more C-C bonds in six-carbon amino linker compared to two-carbon 
amino linker, the total length is ~(2.6 Å x 24) + 8.5 + 5 =75.9 Å. The acceptor-Cy3 attached at 
U6 ISL stacks onto the RNA helix and therefore contributes to the length of the human U6 ISL 
as one additional nucleotide, for a total of 33.8 Å. Triangulation of the lengths of the two stems 
and the distance measured by FRET in the heterogeneous wild-type junction produced an 
average angle of 84.4±3.6°. We note that this value represents a mean between two conformers 
with very different distances, and therefore of limited value. Calculated from individual distances 
obtained from deconvolution of the WT decay curve, 93 Å and 45.3 Å, we obtained values of 
~109.9° for the angle in the majority four-helix conformer, i.e. a large distance between the ISL 
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and Helix I/III stems; calculation of the same angle in the 4HDL1 construct from the directly 
measured distance was 105.2±1.2°, very similar to that obtained by deconvolution. In contrast, a 
distance of 45.3 Å in the three-helix conformer corresponds to a much smaller angle of 19°, 
indicating that even in the absence of all sequence elements necessary for formation of the 
catalytic triplex interaction (pairing of the ACAGAGA loop prevents any tertiary interaction), 
the three-way junction positions the ISL and Helix I/III stems in a much closer orientation than it 
does in its four-helix conformation.  
We also estimated the distance between U6 ISL and Helix I/III values for the minority 
three-helix conformer by subtraction of the measured decay curve for the fraction of four-helix 
fold (91.4%) from that of the (heterogeneous) WT (Figure 2.9). The decay curve of four-helix 
fold is well fitted to a single exponential decay curve with correlation coefficient, R2, = 0.9999, 
whereas the subtracted decay curve for three-helix conformer is less perfectly fitted to a single 
exponential decay curve shown in Figure 2.9 (R2=0.97, calculated using SigmaPlot 13.0; Systat 
Software, Inc., San Jose California USA; www.systatsoftware.com), perhaps as the result of 
several sub-conformers; a similar conclusion was reached from marked 19F peak heterogeneity in 
NMR experiments (Zhao et al. 2013). The distance calculated between U6 ISL and Helix III for 
the remaining three-helix is 56.3 Å, corresponding to an angle of 43.3°. Although there is a 
noticeable difference in the angle obtained by deconvolution and subtraction (19° vs 43.3° 
respectively), this disagreement may result from uncertainty associated with dye/linker mobility, 
heterogeneity of three-helix conformer, the large difference in helix length, and/or the indirect 
nature of the calculation involved for analysis of this minority conformer. However, both values 
indicate an acute angle in the range consistent with the Y shape structure modeled by Butcher 
and coworkers shown previously for the yeast U2-U6 snRNA complex (Burke et al. 2012), 
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implying that the junction has a role in positioning the two helices near to each other.
 
Figure 2.9: Calculation of a decay curve for the three-helix conformer (cyan) by subtraction of 
the experimentally obtained decay curves of fluorescein-labeled 4HJDL1 (orange) from that of 
WTDL (green) without added Mg2+ Concentration of dye-labeled RNA was 150 nM.  time-
resolved FRET measurements were recorded on a timescale of 20 ns to a total of 10,000 counts 
in the peak. The decay curve of fluorescein on 4HJDL1 and WTDL were fit by a mono-
exponential and biexponential curve, respectively, with an excellent R2 (R2>0.999). The 
calculated decay curve for the three-helix conformer in each case was fitted with a mono-
exponential curve yielding a less perfect fit (R2 value ~0.974), suggesting a mix of several three-
helix conformers. 
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2.4.6 Effect of Mg2+ on conformation of the human U2-U6 snRNA complex.   
Both spliceosomes and Group II introns are dependent upon interaction with Mg2+ for 
assembly, including interaction of key sequence elements, as well as for catalytic activity. To 
investigate the impact of Mg2+ addition on the three-dimensional fold of the protein-free human 
U2-U6 snRNA complex, we repeated each of the measurements of interhelical distances in the 
presence of MgCl2 from concentrations of 5 mM (near cellular concentration; (Romani and 
Scarpa 1992) to 40 mM (the value used in previous in vitro studies; (Guo et al. 2009). Results 
indicated a gradual decrease in distance between termini of Helix I/III and U6 ISL in the four-
helix conformation (4HJDL1) with each addition (Figure 2.10). At a final concentration of 
40mM Mg2+, the distance decreased from 90.8±0.6Å to 78.3±0.8 Å, for a decrease in angle from 
105.2±1.2° to 81.3±1.4°, i.e. a closer proximity of Helix I/III and U6 ISL. We also calculated the 
changes in distance and angle in other constructs and the overall data were given in table 2. The 
distance between Helix II and U6 ISL in construct 4HJDL2 (Figure 2.4C) decreased by 5.1Å, for 
a decrease in angle from 110.1±2.4° to 99.1±2.0°. No significant change was observed for 
distance between Helix II and Helix I/III (in 4HJDL3, Figure 2.4D). The distance between Stem I 
and Helix I/III in Construct 4HJDL4 was lengthened slightly by 2.1Å for an increase in angle 
from 139.0±4.0° to 150.5±5.6°, placing Stem I further “behind” the junction. All changes in the 
four-helix conformer upon addition of Mg2+ appear to be in the approach of helices toward the 
U6 ISL, originating from changes in stem orientation, resulting in a more compact folded 
structure. We had previously noted this compaction by increased migration measured by 




Figure 2.10: Decrease in distance between dyes attached to Helix I/III and U6 ISL in construct 
4HJDL1 with respect to increasing Mg2+ concentration from 0 to 40 mM. Error bars indicate ± 
standard deviation.  
 
We then investigated changes in the distribution of four- and three-helix conformers upon 
addition of 40 mM Mg2+. The mean distance between Helix I/III and U6 ISL in heterogeneous 
WTDL shortened by 3.5 Å with added Mg2+, a value much smaller than the change in four-helix 
construct (12.5 Å). However, deconvolution of the decay curves of WTDL upon addition of 
Mg2+ revealed approximately twice the fraction of the three-helix conformer relative to its 
fraction in the absence of Mg2+ (increase from 8.6% to 17% of the total), but also induced 
marked changes in stem orientation. By deconvolution, the distance between Helix I/III and U6 
ISL in the three-helix junction conformer in 40mM Mg2+ increased to 67.7 Å (from 45.3Å), 
triangulated to an angle of 63.1° (from 19°); calculation by subtraction yielded a change in 
















either approach, this change agrees with data from smFRET studies illustrating that addition of 
Mg2+ widens the distance between these stems in the three-helix conformer (Guo et al. 2009).  




Figure 2.11: Calculation of a decay curve for the three-helix conformer (cyan) by subtraction of 
the experimentally obtained decay curves of fluorescein-labeled 4HJDL1 (orange) from that of 
WTDL (green) with added Mg2+ (40 mM). The decay curve of fluorescein on 4HJDL1 and 
WTDL were fit by a mono-exponential and biexponential curve, respectively, with an excellent 
R2 (R2>0.999). The calculated decay curve for the three-helix conformer in each case was fitted 
with a mono-exponential curve yielding a less perfect fit (R2 value ~0.911) 
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Table 2: Distances between dyes labeled at termini of U2-U6 snRNA constructs used in this 
study in solution as described in Materials and Methods, without and with 40 mM added Mg2+.  
Construct 
0 Mg2+ 
Distance Å / (Angle°) 
40 mM Mg2+ 
Distance Å / (Angle°) 
D Distance (Å) 
WTDL 
80.0±2.2 Å 
(Angle not calculated) 
83.5±1.5 Å 
























WT 84.1±1.4 Å† 75.3±2.6 Å† -8.8 







Distances were calculated using Equation 3, for angles defined by dye placement for each 
construct (Figure 2.4), with R0 of 56 Å for the fluorescein-Cy3 pair, and R0 of 70 Å for the 
AF488-AF555 pair. 
†Angle not reported because it is an average angle, a weighted sum of two angles, in two 
conformers and therefore meaningless. 
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††Angle not reported because change in distance is presumably the result of kinking of the 
ACAGAGA loop.  
*Distance and angle between dyes labeled on Helix I/III and U6 ISL in three-helix junction 
model were calculated from deconvolution for the fraction of four-helix fold (construct 4HJDL1, 
which represented ~91.4% and 83.0% of the total in 0 mM Mg2+ and 40 mM Mg2+, respectively) 
from that of the construct WTDL. The number in parentheses is the estimated angle between 
stems.   
 
2.4.7 Simulation and visualization of hU2-U6 snRNA models 
Taken all distance information together, we then tried to visualize conformational 
changes within the human U2-U6 snRNA conformers by simulation without and with 40mM 
added Mg2+. The predictive computational model of two major conformations of hU2-U6 
snRNA complex was obtained by simulation using SimRNA (Magnus et al. 2016), an automated 
and online interface for modeling three-dimensional structure of RNAs. SimRNA uses a coarse-
grained representation of an RNA molecule and the Monte-Carlo method to sample the 
conformational space and statistical potential to introduce the interaction in the RNA folding 
process. The program attempts to predict the structure of an RNA from the primary sequence 
alone by comparison with other known RNA structures. The accuracy of the program can be 
enhanced by incorporation of additional structural information obtained from experiments. In 
this case, we included known secondary structure restraints (base pairing patterns), as well as 
distance restraints between dyes on termini within the U2-U6 snRNA complex obtained from 
time-resolved FRET measurements. Small sources of error can be from the effect of the dye 
mobility and the linker, or insufficient detail about the junction itself. However, because any 
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sources of imperfection remain internally consistent, this form of simulation allows for a good 
assessment of changes in the orientation of stems upon adding Mg2+. The modeled RNA 
structures were then visualized by NGLview (Nguyen et al. 2018), demonstrating the shape of 
two conformers in the wild-type U2-U6 snRNA complex. Without Mg2+, the stem bearing the 
essential catalytic regions (U6 ISL and Helix III/I) are positioned at a long distance in the four-
helix conformer but in a much closer proximity in the three-helix conformer (Figure 2.12A, C). 
In 40 mM added Mg2+, the stems are getting closer in the four-helix conformer representing a 
more compact folded structure, whereas a more open structure is observed in the three-helix 































Figure 2.12: Predictive computational models of the two major conformers of the human U2-U6 
snRNA complex obtained by simulation using SimRNA (Magnus et al. 2016), using distance 
restraints between dyes determined experimentally and visualized by NGLview (Nguyen et al. 
2018). (A) and (B): Models of the four-helix junction conformer (Helix I/III in red; U6 ISL in 
blue; U2 Stem I folded behind the junction in green; Helix II in violet) (A) without Mg2+ and (B) 
with 40 mM Mg2+, showing a compaction of Helix I/III, ISL, and Helix II around the junction 
(Stem I is folded behind the junction in this view). (C) and (D): Models of calculated three-helix 
junction conformer with three helices (Helix I/III in red; U6 ISL in blue; Helix II in grey) (C) 
without Mg2+ and (D) with 40 mM Mg2+, showing a widened junction. The position of Helix II 
in the three-helix conformer was not experimentally determined but found to be in the lowest 
energy position by simulation.  
 
2.4.8 Contribution of the ACAGAGA loop in helix orientation  
To examine the effect of the ACAGAGA loop (i.e., an open loop in the presence of the 
naturally occurring U2 snRNA sequence) to the folding of the complex, we performed the same 
measurements for the distance between Helix I/III and U6 ISL with the wild-type complex 
(Construct WT; Figure 2.4F) and the four-helix mutant (Construct 4HJ; Figure 2.4G), both with 
a native (open) ACAGAGA loop. In both cases, results of time-resolved FRET measurements 
show a small increase of inter-dye distances, from 80.0±2.2 Å (construct WTDL) to 84.0± 1.5 Å 
(construct WT); and from 84.0±1.2 Å (4HJ) to 90.8±0.6 Å (4HJDL1), suggesting that the 
ACAGAGA loop contributes a small kink to Helix I/III in the protein-free U2-U6 snRNA 
complex.  
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There was also no observable change in measurements repeated on constructs in which 
the region of U2 snRNA was paired with a short intron fragment representing the branch site (5'-
UACUAACACU-3' in which all bases are modified to 2′-O-Methyl RNA to enhance the base 
pairing with U2 snRNA and to overcome that between U2 and U6 snRNA). The base pairing 
was confirmed by change in electrophoretic mobility of components using nondenaturing PAGE. 
We had noted previously that the distribution between junction conformations was not altered 
significantly in 19F-NMR spectra in response to the presence or absence of the ACAGAGA loop 
(Zhao et al. 2013). In none of these cases did inclusion of the native ACAGAGA loop, with or 
without pairing to an intron segment, facilitate increased proximity or interaction between Helix 
I/III and the U6 ISL. 
 
2.5 Discussion 
Our goal was to analyze the contribution of the central junction of the spliceosomal U2-U6 
snRNA complex in facilitating splicing activity by positioning of the helices associated with 
formation of the catalytic center. Using protein-free human snRNA complexes labeled at termini 
or internally with fluorescent dyes, results acquired from time-resolved FRET measurements 
enabled characterization of orientation of helical stems about the central junction of for the two 
major folds of the RNA complex characterized by four and three stems emanating from the 
central junction, and changes in conformation and distribution of populations upon incubation 
with Mg2+.  
Genetic studies by Manley identified the importance of formation of the four-helix 
conformer in human cells (Wu and Manley 1989), although the stage in which this conformer 
was critical was not determined. In contrast, genetic studies in yeast  identified a three-helix 
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conformer as the critical conformer (Madhani and Guthrie 1992). Further conformational 
analysis was performed for protein-free U2-U6 snRNA complexes  in vitro, supporting the 
predominance of either the four-helix conformer (Sashital et al. 2004), the three-helix conformer 
(Sashital et al. 2004), or a combination of the two in yeast (Guo et al. 2009) or human (Zhao et 
al. 2013) complexes. These studies suggest the likelihood that the two alternative conformations 
with a small energy difference and distribution between the two may depend on experimental 
conditions. In particular, we confirmed coexistence of the predominant four-helix conformer and 
three-helix conformer and calculated a very small difference in DG between the two 
conformations from NMR peak volumes (4.7 kJ/mol), and verified that the two are in dynamic 
exchange (Zhao et al. 2014). The small difference in energy between the two calculations, by 
FRET and 19F NMR study, may be as the result of small differences in different experimental 
conditions. Also, as noted in the paper describing this work, the area under the 19F NMR peak 
representing the unpaired regions of the junction was exceedingly broad, possibly representing 
several intermediate conformers (Zhao et al. 2013). In contrast with evidence for an equilibrium 
distribution between conformers in vitro, recent results from biochemical structure probing in 
human cells (Anokhina et al. 2013) and by cryo-EM studies of human (Bertram et al. 2017b) and 
yeast (Yan et al. 2015; Rauhut et al. 2016; Plaschka et al. 2017; Wan et al. 2019b) spliceosomes 
illustrate that the more open three-helix junction is generally observed in the intact spliceosomes 
suggesting that this conformation is associated with catalysis. 
The four-helix junction model, measured either by deconvolution of the compound curve of 
the heterogeneous wild type junction or by direct analysis of the mutant favoring the four-helix 
fold, indicated a roughly tetrahedral arrangement of helical stems in the absence of Mg2+. Upon 
addition of Mg2+, the angle between Helix I/III and the ISL decreases with increasing 
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concentration of Mg2+, accompanied by a decrease in the angle between the ISL and Helix II. 
Approach of these two intermolecular stems to the intramolecular (U6) ISL suggests overall 
compaction of the complex. This finding agrees with a decrease in the Stokes radius and axial 
ratio (a/b) measured in the presence of Mg2+ measured by analytical ultracentrifugation (Zhao et 
al. 2013). There is no direct equivalence between the two measurements (i.e. “compaction” 
measured by a change in sedimentation velocity relates only to a change in Stokes radius and 
does not reveal specific changes in specific angles); however, we note that the trend of the two 
Mg2+-induced changes is consistent. This compaction/decrease in angle between ISL and Helix I 
of the four-helix junction conformer suggests that Mg2+ assists in bringing the catalytically 
essential elements into proximity. However, this decrease in distance remains insufficient to 
induce formation of the triplex by itself. 
However, cryo-EM data suggest that the three-helix conformer is associated with catalytic 
activity – so we also investigated the impact of Mg2+ on the three-helix conformer by 
deconvolution of the compound curve of the wild type and, independent, by subtraction of the 
measured four-helix curve of that from the wild type. In contrast with the Mg2+-induced 
approach of critical stems in the four-helix conformer, distances between the same stems in the 
minority fraction characterized by the more open three-helix junction, exhibited a close position 
of the stems in the Mg2+ free state, but responded to Mg2+ by a greatly increased separation 
between the catalytically essential elements. Results were qualitatively similar for both methods. 
Moreover, addition of Mg2+ to complexes containing the heterogeneous wild type junction 
displayed a partial conversion from the four- to the three-helix conformer (~8.6% to ~17% of the 
total). Therefore, the presence of Mg2+ induces changes not only in the equilibrium distribution 
of junction conformers but also the positioning of helical stems around the junction. This Mg2+ 
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induced opening/separation is quite surprising and contrary to one would expect for 
metalloribozyme. Cryo-EM images of spliceosomes trapped in several stages of assembly and 
activity show the U2-U6 snRNA complex as a three-helix junction and with the stems (Helix I, 
Helix II, and ISL) "splayed out" in different directions (Wan et al. 2017). Therefore, it is possible 
that the open, flexible junction undergoes local changes that are not translated into, or detectable 
by, FRET through probes at the termini. More specifically, the stems move further apart in the 
presence of Mg2+ but the very open central junction in the three-helix model could actually 
accommodate the rearrangement and interactions of the elements GAGA (from ACAGAGA 
loop), U6 ISL bulge, and catalytic AGC triad, thus allowing the formation of the triple helix 
interaction as observed in cryo-EM images. We note that a similar finding was reported by 
Rueda and coworkers (Guo et al. 2009) using single-molecule FRET techniques. Therefore, the 
measurement of distances between stem termini by FRET has a limitation for the investigation of 
local changes in the central junction; analysis of FRET data, combined with published data from 
cryo-EM and genetic studies, is therefore likely to provide a more complete and accurate picture. 
Our previously published 19F-NMR study similarly indicated a shift in the distribution of 
conformers to increase the relative population of the three-helix conformer from ~13% of the 
total to ~17%, corroborating the fitting of the decay curve obtained by time-resolved FRET and 
further supporting the conclusion that interaction with, or screening by, Mg2+ shifts the 
conformation of the junction toward the AGC presentation that facilitates catalytic site 
formation. Single molecule FRET studies by Rueda and coworkers on the protein-free yeast U2-
U6 snRNA complex showed the coexistence of at least three conformations: four-helix structure, 
intermediate and three-helix structure (Guo et al. 2009).  It is possible that such an intermediate, 
in equilibrium with other three-helix sub-conformers, contributed to the broad and heterogeneous 
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peak observed in our 19F spectra (and would not have been directly detected by either our NMR 
or ensemble time-resolved FRET approaches). If so, the previous value of ~13% for the 
population of three-helix sub-conformers from 19F NMR is actually an overestimate of the 
population of several three-helix folds or intermediate(s) and is likely to explain the difference 
between measurements of distribution by NMR (Zhao et al. 2013) and time-resolved FRET (this 
work). Our NMR acquisition including a maximum of 5 mM Mg2+ and ~0.35 mM RNA (for a 
ratio of ~14:1), considerably less than the current ratio of 40 mM Mg2+ to 150 nM RNA 
(267,000:1), so this difference in conditions may contribute to some variation in observed 
behavior. Not surprising with such a small difference in energy between two conformers, we 
found that the three- and four-helix conformers of the junction exchange on a sub-second time 
scale (Zhao et al. 2014) 
Rueda and coworkers also observed a significant Mg2+ dependence in the smFRET data of 
yeast U2-U6 snRNA complexes labeled at the 5¢ terminus of U6 and the U6 ISL loop, noting that 
an increase in the concentration of Mg2+ from 0 mM to 40 mM induced a decrease in the 
population of complexes displaying high FRET efficiency (assigned to the four-helix conformer) 
from 64% to 19% (Guo et al. 2009). In a subsequent study of the human U2-U6 snRNA complex 
(Karunatilaka and Rueda 2014), the authors reported that an increase in the concentration of 
Mg2+ from 10 mM to 40 mM resulted in a decrease in the relative population of the four-helix 
conformer from 13% to 5% and in an increase of the three-helix conformer from 44% to 69%. In 
both studies, they attributed this significant change entirely to conversion from four-helix to 
three-helix junction and did not address the possibility of ion-induced change in stem orientation 
in either junction conformer that contributes to such a significant change in FRET efficiency. 
That strick consideration might explain the difference in relative population of two conformers 
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compared to our findings, which was based on direct analysis of the four-helix junction mutant 
confirmed by 19F NMR (Zhao et al. 2014). 
In these experiments, we monitored changes in multiple distances for both the four-helix 
mutant and wild type (mix of four- and three-helix junctions) U2-U6 snRNA complexes with 
increasing concentrations of Mg2+, from which we calculated change in fraction and orientations 
of the junction. By either analysis, results of this experiment provided clear evidence that Mg2+, 
in addition to increasing the fraction of three-helix conformer, induces a marked increase in the 
angle between Helix I/III and the ISL (as well as a more moderate decrease in the angle between 
these stems in the four-helix conformer). The marked increase in  separation between Helix I/III 
and the ISL upon interaction with Mg2+ would decrease the likelihood that the two stems will 
interact to promote catalysis. These findings provide definitive evidence that both the junction 
conformer and helix orientation undergo conformational change in the presence of Mg2+.   
These data suggest that although the junction acts as a Mg2+-sensitive pivot in positioning 
the stems, it alone does not drive the proximity of the stems needed for tertiary interaction. Mg2+ 
clearly brings the catalytically integral elements in the protein-free four-helix junction conformer 
closer but it is not sufficient to form a catalytically active conformation, and the three-helix 
conformer identified in cryo-EM images in the activated spliceosome is actually driven further 
apart from the active conformation for catalysis. It has been proposed that the four-helix junction 
that predominates in the protein-free state (Zhao et al. 2013) exists only to protect the premature 
formation of active site (Sashital et al. 2004), or is simply just a lower energy conformer in vitro.  
While these studies focused on behavior of junction alone, parallel experiments on 
complexes in which the ACAGAGA loop was restored, with or without pairing of the U2 
snRNA side of the ACAGAGA loop with a short fragment to form a branch site helix, found no 
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detectible difference in the distance between the termini of Helix III and the ISL, even in the 
presence of high concentrations of Mg2+ (data not shown). Inclusion of the region of the 
ACAGAGA sequence that participates in the long-range interaction, in the protein-free system, 
is insufficient to promote folding. This observation suggests that although all elements required 
for catalytic activity are present in the RNA, the inability to form or stabilize the active site by 
the U2-U6 snRNA complex alone is mirrored by the exceptionally slow (and low-yield) rate of 
catalysis by the RNA alone, and even then only a modified reaction by sequences with multiple 
mutations to stabilize interaction between the U2-U6 snRNA complex and an intron strand 
(Valadkhan et al. 2009).  
These long-range interactions are structurally equivalent to their counterparts in the Group II 
intron, in which a triple helix is defined by interaction of the Domain 5 bulge and J2/3 with the 
major groove edge of the catalytic AGC triad (Toor et al. 2008).  Crystal structures of a Group 
IIC self-splicing intron identified the importance of an elaborate network of long-range 
interactions to stabilize the catalytic D5 and other components (Toor et al. 2010); this situation is 
not paralleled in the U2-U6 snRNA complex in spliceosomes, where regions of snRNAs not 
directly involved in forming the catalytic site are dispersed in a protein-rich environment (Zhang 
et al. 2019) and references therein). The role of RNA-RNA tertiary interactions involving 
multiple domains to stabilize the catalytic center in the Group II intron is in stark contrast with 
the reliance on protein-RNA interactions to stabilize the catalytic core of the spliceosome, and 





Chapter 3: Interaction of the U2-U6 snRNA complex with NTC-related spliceosomal 
proteins RBM22 and Cwc2.   
(This chapter contains material that has been adjusted from our published paper: Chu H., Perea 
W., Greenbaum, N.L. (2020) RNA, Jul;26(7):836-850. doi: 10.1261/rna.073379.119). 
 
3.1 Introduction 
Results from our studies of conformations of the protein-free U2-U6 snRNA complex 
(chapter 2, Chu et al. 2020) supported the assertion that Mg2+ is an important component in 
formation/ stabilization of the U2-U6 snRNA complex active site. However, in the absence of 
spliceosomal proteins, divalent ions are not sufficient to induce formation of the active site by 
the snRNA components. These findings imply that the context of the U2-U6 snRNA complex in 
the intact spliceosome maintains an essential role in shifting toward the three-helix conformer. 
Protein components clearly fulfill an essential role in facilitating the fold of the U2-U6 snRNA 
complex into a catalytically active fold, which starts to form in the Bact stage (see Chapter 1); 
however, images from cryo-EM studies (Yan et al. 2016) imply that the catalytic Mg2+ ions are 
not fully in place until the B* stage.  
The Nineteen Complex (NTC), with the splicing factor Prp19 at its core, is thought to 
provide a structural scaffold for stabilization of the U2-U6 snRNA complex (Ohi et al. 2005) by 
promoting the RNA-RNA interaction that forms the active site of spliceosome (Chan et al. 
2003). More specifically, NTC-related proteins RBM22 in the human spliceosome and Cwc2 in 
the yeast S. cerevisiae are implicated in the final “remodeling” activity of the spliceosome prior 
to the first step of splicing  (Rasche et al. 2012; Schmitzova et al. 2012). These are the only 
proteins that contact the region surrounding the active site of the RNA complex directly, and 
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they interact with the NTC by noncovalent interactions (McGrail et al. 2009). The essential role 
of Cwc2 in yeast spliceosomes was demonstrated by complete inhibition of the first step of 
splicing upon its deletion from yeast spliceosomes; subsequent supplementation of exogenous 
Cwc2 rescued the catalytic activity (Rasche et al. 2012). Therefore, the NTC is linked to the 
active site of spliceosome through Cwc2 which, by crosslinking, has demonstrated these NTC-
related proteins make contact with U6 snRNA in the 5¢ terminus and the upper part of the ISL 
(Rasche et al. 2012).  
Two separate laboratories have solved crystal structures of Cwc2 (Schmitzova et al. 2012; 
Lu et al. 2012). Both structural models reveal an RNA recognition motif (RRM) and a zinc 
finger (ZnF) domain in the core, with an intervening loop connecting them, that together are 
folded against a toroidal scaffolding domain called Torus. Although it was shown by UV-
induced crosslinking that residues of the protein residing in its RRM, ZnF, and region connecting 
the Torus and RRM domain may be involved in RNA binding, it is not clear precisely which 
region of the protein recognizes which region of the RNA (Schmitzova and Pena 2012). 
Comparison of features of the two NTC-related proteins from human and yeast 
spliceosomes reveals that human RBM22 shares two potential RNA-binding domains with 
Cwc2, the RRM and a zinc finger in the central regions (McGrail et al. 2009). However, RBM22 
contains another region at the N-terminal that homologous to yeast Ecm2, a protein that is 
essential in the formation of Helix II of U2-U6 snRNA complex during spliceosome activation 
(Xu and Friesen 2001); and there is no separate Ecm2-like protein in human spliceosomes. 
RBM22 seems to be the only protein in human that share homology with both Cwc2 and Ecm2, 
therefore, human RBM22 appears to be a fusion protein of the Cwc2 and Ecm2 sequences found 
in yeast, both structurally and functionally (Rasche et al. 2012). Newly published paper has 
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provided evidence suggesting that Ecm2 contacts U2 snRNA and has a role in the formation/ 
stabilization of first-step catalytical site of spliceosome (van der Feltz et al. 2021).  
 We propose that a role of RBM22, as well as a structural role for Mg2+, is to overcome 
the small energy barrier (Zhao et al. 2013) to enable formation of the three-helix junction 
conformer favored in vivo. Since only the three-helix conformer is observed in human cells 
(Anokhina et al. 2013) and in cryo-EM images of spliceosomes trapped in defined stages (Wan 
et al. 2016a; Wan et al. 2016b; Bai et al. 2017; Bertram et al. 2017b; Wan et al. 2017; Bai et al. 
2018; Wan et al. 2019b), and RBM22 is the only NTC-related protein to contact the U2-U6 
snRNA complex directly, we speculate that RBM22 preferentially binds to the three-helix 
conformer, thereby favoring conformational redistribution into the three-helix conformer to 
facilitate formation of the active site.  
In this chapter, we explore the interaction of RBM22 with the human U2-U6 snRNA 
complexes by Electrophoretic Mobility Shift Assay (EMSA) to gain more knowledge about 
remodeling of the catalytically active site of the spliceosome. The results in human are promising 
but technically challenging to achieve due to some difficulties we encountered in the making of 
RBM22. Therefore, future experiments will focus on the analogous yeast system, that is, the 
interaction of protein Cwc2 and the yeast U2-U6 snRNA complex, to take advantage of the more 
soluble protein and the availability of cloned sequences for NTC-related proteins. 
 
3.2 Experimental Designs 
 
3.2.1 RNA constructs 
To examine the difference in affinity between RBM22 and RNA complexes from human 
spliceosomes, we used the complexes WTDL and 4HJDL1 (described in Ch. 2 and shown in 
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Figure 2.4A, B), which differ around the junction: WTDL has a wild-type junction and 4HJDL1 
has a four-helix junction. 
To initiate our study of the interaction of yeast (y)U2-U6 snRNA complexes with Cwc2, 
we built constructs representing a wild-type junction (Figure 3.1). Construct yWT (Figure 3.1A) 
contains native sequence of U2-U6 snRNA from the spliceosome of the yeast Saccharomyces 
cerevisiae. In constructs yWTDPL (Figure 3.1B), the U6 pentaloop was deleted, allowing us to 
label RNA strands with fluorophores at 5' termini and permitting FRET measurements in the 
upcoming experiments; a tetraloop UUCG was introduced to connect U6 and U6 and create a 
“chimeric” U2-U6 strand.  In constructs yWTDAC (Figure 3.1C), the ACAGAGA loop was 
eliminated by modifying yU2 snRNA to form a continuous Helix I/III to enhance base pairing 
between the two RNA strands. In all constructs, the first 5 nucleotides in 5' single stranded 
region of U6 snRNA (G39 included) was truncated and replaced by GG, to increase the 
transcription yield. RNA strands representing 5' fragment of U6 snRNA was synthesized by 
Integrated DNA Technologies (IDTDNA). The yU2, yU6 and yU2-U6 “chimeric” strands were 
obtained by in vitro transcription using T7 polymerase and then purified by ethanol precipitation 
and electrophoresis on a 20% polyacrylamide gel. The concentration of RNA was determined by 
absorbance at 260 nm. Base pairing of strands was confirmed by slower migration of paired 
strands on a 15% non-denaturing PAGE gel run at 4 ℃, 100 V in 30 mM Tris, 60 mM HEPES, 















Figure 3.1: Constructs of yU2-U6 snRNA complex used in these experiments. Inter and intra-
interaction between U6 snRNA (black) and U2 snRNA (light blue) form Helix I (Ia, Ib), Helix II, 
Helix III and U6 ISL. The first 5 nucleotides in single stranded region of 5' of U6 snRNA was 
truncated and replaced by GG, to increase the transcription yield in all constructs. A pentaloop 
on U6 ISL in construct yWT (A) was removed and a tetraloop UUCG was introduced to 3' of U6 
snRNA to connect with U2 and create a “chimeric U2-U6 strand” in construct yWTDPL (B).  
The ACAGAGA loop (light green shade) was closed by modifying U2 snRNA sequence 
opposing of U6 snRNA (nucleotides in red) to form a continuous helix I/III in construct 




3.2.2 Protein expression. 
Both spliceosomal proteins (human RBM22 and yeast Cwc2) were expressed and 
purified using essentially the same procedure. RBM22 fragment (146-420) was cloned in BL21 
cells containing an engineered pET-15b plasmid by GenScript and Cwc2 is in Rosetta-2 cells 
with a pETM11 plasmid (plasmids containing these sequences were a gift from the laboratory of 
Prof. Reinhard Lührmann, Max Plank Institute for Biophysical Chemistry).  
Cells were incubated at 37 ℃ until OD600 ~ 0.6 was reached, and at 17 ℃ for induction 
with 1mM IPTG, then harvested after 24 hours. Cell pellets were first suspended in lysis buffer 
(50 mM HEPES, pH 7.5, 2mM 𝛽-mecaptoethanol) containing RNase I, sonicated with a Sonic 
Dismembrator at Set 3 (10-11 Watts), and then centrifuged at 10000 rpm at 4℃ for 1hour. 
Supernatant containing soluble protein was purified by ion-exchange chromatography (IEX), 
followed by Immobilized Metal Affinity Chromatography (IMAC). Lysate supernatant was 
loaded on HisTrap SP 5ml column and eluted with a gradient of NaCl (from 0 M to 1 M 
concentration). The fractions containing most of protein from IEX were purified further by 
IMAC in an ÄKTA Purifier FPLC (GE Healthcare) with HisTrap HP 5 ml column and eluted 
with an Imidazole gradient (from 10 mM to 1 M). The eluent was dialyzed against phosphate 
buffer containing 20 mM NaPi, 100 mM NaCl, 1 mM DTT, 5% glycerol, pH 6.5 using a Float-
A-Lyzer with molecular weight cut off (MWCO) of 20 kDa and then concentrated down to 200-
400 𝜇l using Amicon Ultra centrifugal device (Millipore) with MWCO of 3kDa. Purify and 
integrity of protein was confirmed by migration on a SDS-PAGE gel and a non-denaturing 
PAGE gel which were visualized by staining with Coomassie® Blue. Protein concentration was 
determined using Bradford Assay using the Coomassie® Protein Assay Reagent Kit from Pierce 
Biotechnology with BSA as a standard.  
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3.3 Electrophoretic Mobility Shift Assay (EMSA) for protein-RNA interaction 
investigation. 
The Electrophoretic Mobility Shift Assay (EMSA) has been long used to characterize and 
quantify interactions between proteins and nucleic acids (Revzin et al. 1986; Fried 1989; 
Hellman and Fried 2007). It is based on the difference in electrophoretic mobility of a protein-
nucleic acid complex relative to that of the free protein and free nucleic acid in a non-denaturing 
polyacrylamide gel at physiological pH.  
We investigated the affinity of the protein-RNA interactions by use of a label-free 
horizontal EMSA gel, described in (Perea and Greenbaum 2020), in which the wells are placed 
in the middle of the gel.  The advantage of this method is that it allows separation and 
visualization of both positively charged (basic) protein and negatively charged (acidic) RNA as 
free molecules as well as the RNA-protein complex on the same gel (Figure 3.2). Briefly, the 
working pH is near neutral and intentionally selected to guarantee that the protein (RBM22, 
Cwc2) is positively charged and runs to the cathode whereas RNAs run toward the anode. The 
RNA-protein complex moves at slower rate, relative to free protein or free RNAs, as a result of 
its increased size and lower mass:size ratio. In this study, the RNA concentration remained 
constant, while the concentration of proteins varied. The protein-RNA mixtures were prepared in 
NaPi buffer pH 6.5 and incubated at room temperature for 1 hour, then loaded on an EMSA gel. 
The gel was run in 30 mM MOPs, 25 mM Histidine buffer pH 6.5 at 4℃ for 90 minutes.  
Because all species remain in the gel, it is possible to stain for bands including the RNA as 
well as those containing protein. The resulting gel was stained with SYBRTM Gold for 1 hour, 
allowing RNAs and protein-RNA complex to be visualized at 302nm. Subsequentially, the same 
gel was stained with Coommasie® Blue overnight and only protein and protein-RNA complex 
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bands were exposed. Images from the gel allowed us to quantify the band intensities, thereby 
dissociation constant (Kd) of protein-RNA interaction via relative concentrations of bound and 




Figure 3.2: A diagram to illustrate how protein, RNA and protein-RNA complex migrates in a 
label-free horizontal non-denaturing EMSA gel. The protein is positively charged and run to the 
cathode whereas the RNA is negatively charged and run to the anode. The protein-RNA complex 
migrates at a slower rate relative to free protein or free RNA. Picture is from (Perea and 








3.4.1 Binding of NTC-related protein RBM22 to human U2-U6 snRNA complex.  
To test the hypothesis that RBM22 binds preferably to the three-helix conformer which is 
the only conformer observed in vivo, we investigated the relative affinity of recombinant RBM22 
for the wild-type junction (construct WTDL) and four-helix junction mutant (construct 4HJDL1) 
by EMSA gel. The concentration of RNA constructs (wild-type junction and four-helix junction 
mutant) was kept constant at 10 µM while we varied concentration of RBM22 from 5 µM to 15 
µM.  Results from EMSA measurements (Figure 3.3) exhibit a greater affinity of RBM22 for the 
wild-type complex. Using UVP Visionworks software (https://www.uvp.com/), we quantified 
the intensity of each band allowing us to determine the Kd for each protein-RNA complex. 
Binding curves were fitted by a one-site binding (hyperbola) model using Prism 
(https://www.graphpad.com/scientific-software/prism/). Goodness of fit was evaluated by a least 
squared fit R2 with 95% confidence intervals, yielding a Kd of 8.3±1.2 µM for the wild-type 
junction, compared to a much higher Kd of 37.1±10.5 µM for the four-helix junction mutant 
(Figure 3.4), suggesting that RBM22 binds tighter to the three-helix conformer in the wild-type 




Figure 3.3: EMSA gel showing the binding of RBM22 with Construct WTDL (lane 1, 3, 5) and 
Construct 4HJDL1 (lane 2, 4, 6). The concentration of RBM was remained constant at 10 µM in 
all lanes whereas the concentration of RNAs varied from 5 µM to 15 µM. The gel was run in 30 
mM MOPs, 25 mM Histidine buffer pH 6.5 at 4℃ for 90 minutes and then stained with 
Commasie® Blue overnight. Only RBM22 and RNA-RBM22 complex bands were exposed after 
staining with Commasie® Blue in this gel. The bands represent the RNA-protein complex which 
was visualized at 302 nm. The gel visually shows a greater binding affinity of RBM22 toward 
the wild-type complex. 
Lane 1: 5 µM WTDL + 10 µM RBM22 
Lane 2: 5 µM 4HJDL1 + 10 µM RBM22 
Lane 3: 10 µM WTDL + 10 µM RBM22 
Lane 4: 10 µM 4HJDL1 + 10 µM RBM22 
Lane 5: 15 µM WTDL + 10 µM RBM22 










Figure 3.4: Analysis of binding affinity of construct WTDL (A) and construct 4HJDL1 (B) to 
RBM22. Concentration of RNA was constant at 15 µM and RBM22 concentration varied from 6 
µM to 22.5 µM, corresponding to the RNA:RBM22 ratio varying from 1:0.4 to 1:1.5. Binding 
curves were fitted by a one-site binding (hyperbola) model using Prism Graphpad 
(https://www.graphpad.com/). Goodness of fit was evaluated by least squared fit R2 with 95% 





3.4.2 Binding properties of NTC-related protein Cwc2 to the yU2-U6 snRNA complex.  
In the process of investigating the interaction of human spliceosomal protein RBM22 
with the human U2-U6 snRNA complex, we faced challenges regarding yield, stability, and 
solubility of RBM22. Despite significant efforts to express and purify RBM22, the yield was 
low, and the protein was not structurally stable (resulting in aggregation when stored at -
20℃	for	two	weeks) to carry out our experiments to the final stage. Recognizing these obstacles, 
we tried to investigate the RNA-protein interaction using the same method using the yeast 
spliceosomal protein Cwc2 (a partial analogue of RBM22 in yeast, discussed in section 3.1) and 
the yeast U2-U6 snRNA complex, knowing that it might be a better alternative model for study.   
To examine the specificity of the interaction between Cwc2 and yU2-U6 snRNA 
complex, we compared the affinity of interaction between Cwc2 and construct yWT (Figure 
3.1A) using a commercial mixture of tRNA from E. coli (New England Biolabs, Inc) as a 
control. Cwc2 does not bind to tRNA, reflected by insignificant change in mobility of Cwc2 
upon incubation with tRNA. However, it binds strongly to yU2-U6 snRNA complex, suggesting 
that binding to yU2-U6 snRNA complex is specific (Figure 3.5). We also investigated interaction 
between Cwc2 and the individual strands of yU2-U6 snRNA and as a complex (Figure 3.6). 
Cwc2 binds to yU6 with a single shifted band and similar intensity to that of yU2-U6 snRNA 
complex. This is a reasonable finding because the same protein-binding regions in yU2-U6 
snRNA complex are also present in yU6 alone. Incubation of yU2 with Cwc2 results in two 
weaker bands on the gel for binding of Cwc2 to yU2, suggesting multiple lesser affinity sites or 
different binding stoichiometries. Studies with Cwc2 from which the unstructured C-terminal 
segment (residues 230-339) yielded the same observation as with full-length Cwc2, suggesting 
that the unstructured C-terminus of Cwc2 is not involved in specific recognition of the RNA 
 82 
target protein (Figure 3.7). However, removal of C terminal region results in decreased binding 
affinity, particularly for U2 snRNA alone, suggesting that the C-terminal segment of Cwc2 may 
interact with the open junction, probably with nucleotides in U2 snRNA. This observation is 
interesting because U2 was not shown to interact with Cwc2 in cross-linking experiments in 
which the C-terminal was removed (Rasche et al. 2012). These experiments were performed by 




Figure 3.5: EMSA gel showing the specificity interaction of construct yWT (Figure 3.1A) with 
Cwc2. The gel was stained with Coommasie® Blue overnight, revealing only protein and 
protein-RNA complex. Lane 1: Cwc2 upon incubation with yU2-U6 snRNA complex. Lane 2: 
Cwc2 upon incubation with tRNA. Lane 3: Cwc2. Lane 4: tRNA. The RNA in lane 4 serves as a 






















Figure 3.6: Interaction of Cwc2 with yU2-U6snRNA (construct yWT; Figure 3.1A), as 
individual strands and as a complex. The gel was stained with Coommasie® Blue overnight, 
showing interaction of Cwc2 with yU2, yU6 and yU2-U6 snRNA complex. Lane 1-3: yU2, yU6 
and yU2-U6 snRNA complex, respectively, are not visible in this stained gel; Lane 4: Cwc2 
only, migrating to the cathode (marked with -). Lane 5, 6, 7: RNA-conjugated protein complex 
as Cwc2 interacts with yU2, yU6 and yU2-U6 snRNA complex.  















Figure 3.7: Interaction of Cwc2△C with yU2-U6 snRNA - construct yWT (Figure 3.1A), as 
individual strands and as a complex.  The unstructured C terminal region including His-tag was 
removed by limited enzymatic proteolysis and then the protein was incubated with RNAs. Lanes 
1-3: incubation with snRNA results in a shift toward the anode; incubation with the U2-U6 
snRNA complex resulted in the strongest shift and clearest band, suggesting the highest affinity 
interaction.  RNAs in lane 4, 6, 7 are invisible in this stained gel. Cwc2 in lane 5 moves to the 
cathode (marked with -).  
  
   –     +  
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 We next created construct yWTDPL (Figure 3.1B) that allows us to attach fluorophores to 
5' of each RNA strands through which changes in distance between stems bearing catalytically 
critical elements, i.e., Helix III/I and U6 ISL, can be measured by FRET measurements in future 
experiments. In this construct, the pentaloop on U6 ISL was removed and a tetraloop was 
introduced to connect 5' of U2 and 3' of U6 snRNA. However, we had trouble with base pairing 
of this construct under experiment conditions; therefore, we modified the strand sequences to 
enhance base pairing by modifying U2 snRNA to have a complementary sequence to 
ACAGAGA box of U6 to create construct yWTDAC (Figure 3.1C). These modification sites are 
within regions shown to crosslink to Cwc2 (Rasche et al. 2012), which include U6 ISL and 5' 
flanking regions of U6 snRNA (Figure 1.14).  
To examine the impact of these changes on the interaction of Cwc2 and yU2-U6, we 
measured Kd of these two complexes with Cwc2 by EMSA. These experiments were performed 
with the assistance of NamHee Kim, an undergraduate student in our laboratory, under my direct 
supervision. The RNA concentration was remained constant at 15 µM and protein concentration 
varied from 3 µM to 18 µM, corresponding to RNA: protein ratio changing from 1:0.2 to 1:1.2. 
RNA was incubated with protein for 1 hour at room temperature before loading onto the gel. 
EMSA gels were electrophoresed at 4°C for 90 minutes, then stained with SYBRTM gold for 1 
hour, to visualize RNA and formation of the RNA-protein complex, and with Coommasie® Blue 
overnight to observe protein and the RNA-protein complex as described in section 3.3 and in 
(Perea and Greenbaum 2020).  Results from EMSA (Figure 3.8A and B for staining with SYBR 
gold and Commassie Blue, respectively) were then plotted (Figure 3.8C); these data indicated a 
low Kd value = 2.01±0.75 µM for interaction of construct yWTDPL (open ACAGAGA loop) 
with Cwc2 and a higher Kd = 4.06±2.27 µM value (and also greater variance) for construct 
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yWTDAC (closed ACAGAGA loop) and Cwc2 (Figure 3.9). The low Kd value of both 
constructs with Cwc2 suggests fairly high affinity but reasonable for RRM and ZF binding; and 
interaction with the U6 ISL pentaloop does not contribute measurably to interaction between 
Cwc2 and the yU2-U6 snRNA complex. In addition, the lesser affinity of binding with yWTDAC 
suggests that the possibility that the ACAGAGA loop contributes (albeit not significantly) to the 




















Figure 3.8: EMSA gel showing interaction of yWTDPL and Cwc2 (A, B) and analysis of binding 
affinity of the two (C). Gel was stained in EtBr (A) revealing RNAs as individual strands and as 
in complexes. The same gel was stained with Coomassie Blue (B) revealing proteins and RNA-
conjugated proteins. Bands were visualized under UV light at 302 nm and intensities were used 
to determine the Kd for the interaction. 
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Figure 3.9: EMSA gel showing interaction of yWTDAC and Cwc2 (A, B) and analysis of 
binding affinity of the two (C). Gel was stained in EtBr (A) revealing RNAs as individual strands 
and as in complexes. The same gel was stained with Coomassie Blue (B) revealing proteins and 
RNA-conjugated proteins. Bands were visualized under UV light at 302 nm and intensities were 
used to determine the Kd for the interaction. 
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 In this chapter, we investigated the interaction of U2-U6 snRNA complex with proposed 
splicing remodeling proteins of yeast and human spliceosomes. The results from EMSA provide 
ground knowledge for any time-resolved FRET measurements in the future to learn about 
conformational changes induced by spliceosomal proteins, by which the active site of 
spliceosome is remodeled into its active form.  
In human spliceosomes, it has been shown that the folded state of the U2-U6 snRNA 
complex starts to form in the Bact stage, but that the final stabilization of RNA and catalytically 
essential Mg2+ ions is not complete until the B* stage, immediately before the first step of 
splicing.  We therefore anticipate that binding of RBM22 (or Cwc2 in yeast), in association with 
NTC proteins, in addition to anchoring distant regions of the RNA complex, acts as a scaffold for 
the central junction and precise positioning of the catalytic Mg2+. By EMSA affinity analysis, we 
showed that RBM22 binds more tightly to the wild-type complex than it does to the four-helix 
junction mutant, suggesting that RBM22 preferentially binds the more open junction in the three-
helix conformer in addition to other sites identified by cross-linking. This additional interaction 
or feature was not discerned in earlier cross-linking experiments (Rasche et al. 2012). This 
preference for the three-helix conformer shifts equilibrium values of the two junction conformers 
to favor the three-helix form observed in active spliceosomes, thereby explaining the prevalence 
of this conformation in the spliceosome, as seen in human cells and cryo-EM studies, where it 
would permit formation of the catalytically active form.  
Study of a partial analogue of RBM22 was accomplished by initiating interaction of a yeast 
protein, Cwc2, with yU2-U6 snRNA complex demonstrates specific binding between them. 
Apart from the binding sites within the RNA complex identified by crosslinking (Rasche et al. 
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2012),  we, for the first time, showed that Cwc2 has contact with yU2 snRNA, however, the 
binding is not as strong as to yU6 snRNA or the RNA complex. The specific binding between 
RNA complex and Cwc2 suggests an essential role of the protein, to coordinate the catalytically 
essential elements of the active site and therefore, form a specific conformation of the RNA 
complex. 
Cwc2, with or without the C-terminus, can bind to each RNA strand individually or as in 
RNA complex, although it shows greater affinity for the complex, suggesting that its 
unstructured region at C terminal does not contribute greatly to RNA-protein interaction. 
Interestingly, removal of the C-terminus of Cwc2 does not inhibit binding to U2-U6 snRNA 
complex or U6 only but results in significantly less binding to U2 snRNA, raising the speculation 
that the C terminal domain interacts with the single stranded region of U2 snRNA in the 
junction. For FRET experiments, the C terminal of Cwc2 can be removed and its truncated 
version can be used in future experiments, allowing us to have a well-behaved protein without 
significantly compromising the interaction between RNA complex and protein in our studies. 
Future experiments will also address the relative affinity of binding for the three-helix vs. four-
helix conformers using a full-length Cwc2. This part of the study will be facilitated by the ability 
of independent mutations to be made in the yeast U2-U6 snRNA complex to favor formation of 
the three-helix or four-helix mutants, respectively (Guo et al. 2009), whereas sequence 
differences in the human U2-U6 snRNA complex only allow for mutants favoring the four-helix 
conformer (Zhao et al. 2013).   
Affinity analysis of construct yWTDAC (Figure 3.1C), in which the ACAGAGA loop, U6 
pentaloop and G39 nucleotide at the 5' single stranded region of U6 were removed, shows a tight 
binding to Cwc2. These removed regions are shown to have interaction with Cwc2 (Rasche et al. 
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2012), indicating that those regions only account for a fraction of binding affinity. It is in 
agreement with other study in our lab (Ciavarella et al. 2020), suggesting that additional contacts 
that do not participate in cross-linking are important for interaction, and perhaps for their role in 
RNA folding. One possibility is the unpaired region of the central junction, especially the more 





Chapter 4: Conclusions and Future Directions  
 
4.1 Conclusions  
The overall goal of the work described in this dissertation is to investigate how the U2-
U6 snRNA complex folds into the catalytically active state, in which regions with catalytically 
essential elements are brought into proximity and form a triple helix interaction, observed by 
cross-linking (Anokhina et al. 2013), genetic studies (Fica et al. 2014) and in cryo-EM based 
models (Anokhina et al. 2013; Yan et al. 2016).  More specifically, we first modeled the three-
dimensional conformation of protein-free human U2-U6 snRNA complex in the ground state and 
then studied changes in conformation of the complex upon addition of divalent metal ions and a 
spliceosomal protein shown to be critical for splicing activity (Rasche et al. 2012). 
 Using Fluorescence Resonance Energy Transfer (FRET) measurements as the approach, 
we were able to build a three-dimensional model of two major conformations of protein-free U2-
U6 snRNA complex in the ground state, with and without Mg2+.  We showed that the human 
snRNA complex adopts two major conformations: a tetrahedral four-helix junction and a Y-
shape three-helix junction. These findings are in good agreement with results previously 
acquired by 19F-NMR techniques by the Greenbaum Laboratory (Zhao et al. 2013). Mg2+ induces 
conformational changes differently in two conformers in the opposite direction. In the four-helix 
junction, Mg2+ brings the stem bearing the catalytically integral elements closer, making the 
conformer more compact. On the other hand, the same stems in the three-helix conformer 
becomes more open. This finding suggests a role for Mg2+ in the activation of the active site by 
screening charges associated with stem backbones, thus allowing them to approach each other. 
We also found that Mg2+ induces partial interconversion from four-helix conformer to the three-
helix conformer to create a more relaxed structure. This result, too, had been noted in findings 
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from the NMR studies (Zhao et al. 2013). We point out that none of these results rule out the 
possibility that an intermediate exists as suggested by (sm)FRET (Guo et al. 2009). Most 
importantly, we showed that in neither of these models, the stems bearing the catalytically 
critical components come close to form the triple helical active state; clearly other components, 
in the form of spliceosomal proteins, are required to facilitate and stabilize the catalytically 
active conformation.   
The Nineteen complex-related proteins, RBM22 in the human spliceosome and Cwc2 in 
the yeast S. cerevisiae, are implicated in the final “remodeling” activity of the spliceosome prior 
to the first step of splicing (Rasche et al. 2012; Schmitzova et al. 2012). We therefore examined 
the interaction activity of snRNA complex and spliceosomal proteins in both human and yeast by 
Electrophoretic Mobility Shift Assay (EMSA). An interesting finding is that for the first time, we 
showed that RBM22 has higher affinity for the three-helix conformer than for the four-helix 
conformer in human. This finding implies that there are additional contacts in the region of the 
junction, perhaps forming a scaffold that facilitates tertiary interactions; such an interaction had 
not been observed in cross-linking studies (Rasche et al. 2012). We have not yet been able to 
pursue this study in the yeast system; however, we suspect that the same tendency occurs in 
yeast. We also showed that Cwc2 has specific interaction with yU2-U6 snRNA complex to 
stabilize a specific conformation of the RNA complex in the active site. One reasonable 
explanation for all these findings is that spliceosomal proteins, together with Mg2+, create an 
environment and interactions that help overcome the small energy barrier (calculated based on 
19F NMR study (Zhao et al. 2013) and our FRET study (Chu et al. 2020) needed to favor 
interconversion from the lower energy four-helix conformer to the higher energy three-helix 
conformer seen in the spliceosome by cryo-EM studies.  
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Cryo-EM images have provided unprecedented structural information of complexes of 
spliceosome at defined stages. However, they do not explain the roles of direct interaction or 
relationship between these stages or how the RNA complex can overcome such an energy barrier 
to favor the formation of active site. By FRET measurements and EMSA analysis, we have been 
able to analyze and answer some questions that are not answered by static structural methods.  
 
4.2 Future directions  
Future experiments will focus on the yeast system, as Cwc2 is more “well-behaved” than 
the human protein RBM22, as well as the availability of cloned sequence for other NTC-related 
proteins. For FRET experiments, we will label the 5' terminus of RNA strands in different 
constructs (Figure 3.1B, C) with donor and acceptor dyes. This labeling strategy will allow us to 
measure distance between stems by time-resolved FRET measurements. Results can then be used 
to analyze any conformational changes induced by Cwc2.  
Another advantage of the yeast snRNA complex is that we were unable to design a 
mutant favoring the three-helix junction in the human U2-U6 snRNA without inducing a number 
of anomalous conformers (Zhao et al. 2013); however, Rueda and coworkers have shown that 
such a mutant can be created for the yeast U2-U6 snRNA complex (Guo et al. 2009). The 
availability of mutants forming the two different conformers will allow us to address the relative 
affinity of protein binding for both the three-helix and four-helix conformers in future 
experiments. The position of Helix II in the human U2-U6 snRNA was not experimentally 
determined in our previous study (details in chapter 2). However, with the three-helix mutant in 
yeast, it should be possible to construct a more accurate model for the three-helix junction 
without the need for indirect calculations used for the human snRNA complex. Results from this 
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study will enable us to see the long-range structural changes that must occur to enable formation 
of the active site. 
New evidence recently comes to light indicating that Ecm2 has a distinct role in the 
formation/ stabilization of the first step catalytical core (van der Feltz et al. 2021). This new 
work opens the door for additional studies, and maybe gives us an opportunity to investigate the 
role of each protein individually to understand its contacts with snRNA complex and remodeling 




Figure 1: The exponential decay fitting process for the Donor (fluorescein or AF488) undergoing 
FRET to Acceptor (Cy3 or AF555) in each of designed constructs. The blue decay curve is 
instrument response. The red decay curve is for the donor in response to pulses at 495 nm. The 
solid green curve is the fitted curve by a mono or biexponential curve (upper) with a display of 
residuals derived from fit indicates a good fit (lower) in each of measurements.  
A: Construct 4HJDL1 
B: Construct 4HJDL2 
C: Construct 4HJDL3 
D: Construct 4HJDL4 
E: Construct WT 























Figure 2: Decay curve of the donor (fluorescein) in construct 4HJDL1 with respect to increasing 
Mg2+ concentration from 0 to 40 mM. Red: Decay curve of the donor only; Green: Decay curve 
of the donor in the presence of acceptor (Cy3) in no Mg2+; Purple: Decay curve of the donor in 
the presence of acceptor (Cy3) in 10mM Mg2+; Blue: Decay curve of the donor in the presence 
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